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INTRODUCTION
Neurological injuries, such as stroke and spinal cord injury often result in physical 
impairments that interfere with a person’s ability to walk.1 Loss of walking ability 
often creates dependency on a wheelchair or other assistive mobility devices like 
ankle foot orthoses or canes.1 The ability to walk is an important prerequisite for the 
performance of many daily-life activities. For many people with neurological injuries, 
recovery of walking ability is one of the most important goals during rehabilitation 
and gait therapy is, therefore, a key component of the rehabilitation program for 
these persons.2,3 In addition, walking ability largely contributes to the overall fitness 
level of the patient which in turn influences the health status of the patient.4 As such, 
optimization of therapeutic methods/techniques to improve walking has received 
considerable attention during rehabilitation and in research. Several treatment 
approaches to re-learning motor function and performance have been used so far.5 
However, treatment outcomes are still not satisfactory in many cases and therefore, 
many scientists are studying how to best improve walking ability in neurological 
patients.
This introduction outlines the focus of this thesis: the recovery of walking ability 
using a robotic device. It shortly introduces two neurological injuries (stroke and 
spinal cord injury) that often have devastating influence on the lives of the individuals 
affected by the injury. Furthermore, this introduction will provide a very short history 
of the development of the concept of robot-assisted therapy. Finally, it will describe 
the questions addressed in this thesis.
Stroke
During stroke or cerebrovascular accident (CVA), brain cells get deprived of 
oxygen resulting in damage to the involved brain area. Deprivation of oxygen can 
be a result of disrupted blood circulation in the brain by either an obstruction in an 
artery (ischemia) or by a rupture of one of the blood vessels (hemorrhage) in the 
brain. As a consequence, the functions of the involved parts of the brain are impaired. 
For example, if brain areas involved in motor functions are damaged, this results in 
impairment of movements on the side contralateral to the side of the damage to 
the brain. Depending on the location and severity of the lesion, stroke may result 
in motor impairments, sensory impairments, balance problems, speech disorders, 
visual field defects and changes in cognitive and emotional functioning. Stroke is a 
leading cause of mortality and disability in the western world.6 Presently, more than 
35000 people in the Netherlands suffer from a first ever stroke each year7 of whom 
almost 9000 die as a result of this stroke (shortly) after onset. For the survivors, as 
many as 80% initially loose walking skill.8 Although substantial recovery from the initial 
impairments is commonly observed in these patients, after 6 month of rehabilitation, 
half of the survivors still suffer from remaining impairments.9
Spinal cord injury
A variety of symptoms are associated with spinal cord injury (SCI), depending 
on the size and the location of the lesion. The spinal cord houses many ascending 
and descending sensory and motor tracts. Lesions in the spinal cord can cause a.o. 
(partial) paralysis of the muscles below lesion level, like muscles of the legs and 
arms, loss of sensation, neuropathic pain, incontinence, loss of sexual function, 
abnormal blood pressure regulation, disturbed heart rate control or impaired sweat 
regulation.10 These lesions also often result in spasticity (involuntary activation) 
of affected muscles 10. The incidence of traumatic SCI varies from 2.3 to 83.0 per 
million.11 In the Netherlands, the incidence of a traumatic SCI is about 170 individuals 
per year.12 Almost 60% of lesions are incomplete lesions.12 Early after the injury, 
recovery is possible, especially for individuals with incomplete lesions, however, 
between 9 and 18 month, recovery plateaus.13 About 50% of ASIA B (sensory but not 
motor function is preserved14), and 75% of ASIA C (motor function is preserved in more 
than half of key muscles14) will become ambulatory.15 During rehabilitation, recovery 
of walking ability has a high priority for patients with incomplete spinal cord injury.2 
A history towards the concept of robot assisted gait therapy
In a quest to understand the neurological organization of gait, studies revealed 
that animal and human walking is not only controlled by the brain.16 A large role of 
the neurological control of walking is reserved for the spinal cord. The spinal cord 
has so-called Central Pattern Generators (CPGs) which are able to generate rhythmic 
neural activity without input from the brain. This rhythmic activity is employed in 
many species for locomotion. These CPGs can be activated using sensory information 
from the legs without input from the brain. There are several reviews on the topic of 
the neurological organization of gait available in the literature.16,17 A striking research 
finding on the CPG has been that cats with a fully transected spinal cord are capable 
of supported hind-limb stepping on a treadmill.18 After a few weeks of therapy 
on a treadmill, these cats became fully weight bearing and could walk at various 
speeds with a near normal kinematical pattern. Since humans also possess CPGs, 
such findings provided the basis for the concept of walking therapy on a treadmill 
in humans with neurological injury. During the proposed treadmill therapy, body 
weight was supported by a weight bearing harness in which patients were suspended 
above the treadmill. It was suggested that such a therapy might tap into this CPG 
subsystem and contribute to enable walking in highly impaired patients19 and this 
therapy seemed to be task-specific and to provide progressive practice. Gradually, 
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this therapy called Body Weight Supported Treadmill Training (BWSTT), was further 
developed and tested in experimental studies, the results of which indicated that 
patients who were treated with BWSTT improved more than expected compared 
to (historical) controls who had received conventional overground rehabilitation.20-22 
In the nineties, in more and more rehabilitation hospitals BWSTT became standard 
therapy in the rehabilitation after neurological injuries, especially in the United States 
(the NeuroRecovery Network). Typically, in rehabilitation practice, the therapy works 
as follows: a patient, supported by a weight bearing harness, is suspended above a 
treadmill while therapists assist the legs in the kinematics of walking. In some cases, a 
third therapist is also involved for e.g. stabilizing the torso of patients. Because of the 
apparent repetitive character of this type of therapy, it is suited for automation using 
robotics.23,24 Therefore, at the start of this millennium, cleverly engineered, robot 
assisted walking devices became commercially available for rehabilitation centers. 
The first commercially available ‘driven gait orthosis’ device was the Lokomat.23,24 
The Lokomat consists of a treadmill, a body weight support system and two robotic 
othoses in which the legs of a patient can be strapped, to allow guidance of the leg 
while walking on the treadmill (Figure 1).
Figure 1: The Lokomat device
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Possible benefits of the Lokomat 
Recovery is a complex process involving both spontaneous improvements and 
learning dependent improvements.25 Besides the ‘spontaneous neurological recovery’ 
present in both CVA and SCI13,26 neurorehabilitation therapies can enhance neural 
recovery and help patient to learn strategies to deal with existing impairments.26,27 
Currently several recommendations are made with regard to effective therapy.25 
Therapy should start soon after neurological injury and be high-intensive, repetitive 
and task-specific.25 All these ingredients are present during Lokomat therapy to 
improve walking ability.28,29 Additional advantages of the Lokomat seemed to be that:
• Physical strain on trainers/clinicians is relieved
• Only a single therapist is involved 
• Longer and more intensive training sessions are possible
Moreover, improving or maintaining physical fitness is another important 
objective of rehabilitation. Participation in aerobic training and muscle strengthening 
activities seems to results in higher levels of physical fitness and reduces the risk for 
premature chronic health conditions and mortality.30,31 As patients may train longer 
at higher intensities in the Lokomat than during conventional therapies Lokomat 
training may have some advantages over conventional therapy as a potential aerobic 
exercise mode.32
Need for investigation
A few studies had been published showing encouraging results in pilot RCTs 
for both stroke and SCI by the start of this research program.29,33-35 However, no 
large randomized studies were available in March 2008 and the Lokomat had been 
further developed in the mean time. These developments were mainly in terms of 
improvements in the controllers of both the bodyweight support and the algorithms 
of the controllers of the guidance of the legs.36 Together, it was, therefore, deemed 
necessary to further study the effects of the device in terms of effectiveness in 
improving walking ability.
Furthermore, clinical observations had already shown that patients fatigued even 
after a short bout of therapy in the device, and literature suggested that treadmill 
walking may be used for aerobic training.37,38 Therefore, it was anticipated that 
neurological patients’ fitness may be improved by automated therapy. Decreased 
cardiorespiratory fitness might lead to a further decrease in activity resulting in a 
vicious circle.39 Robot assisted therapy might be a useful tool to break this circle 
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by improving cardiorespiratory fitness in neurological patients. Therefore, gaining 
insight into the potential to improve neurological patients’ fitness by automated 
therapy was considered important.
Aim of the thesis
The goal of this thesis was to evaluate the use of the Lokomat in rehabilitation 
after stroke and spinal cord injury. For this purpose several objectives were defined. 
The first important goal of the thesis was to evaluate Lokomat therapy in the 
rehabilitation of stroke patients and persons with incomplete SCI by investigating 
the effectiveness of an intervention with the Lokomat on recovery of walking ability. 
The second objective was to evaluate walking in the Lokomat in terms of muscle 
activity and in terms of the potential for improvements of cardiorespiratory fitness 
in these patients.
Outline of the thesis
Essentially, this thesis deals with two different patient groups. Chapters 2 to 5 
are related to stroke patients and chapters 6 and 7 are related to spinal cord injured 
persons. This thesis starts by an evaluation of muscle activity of stroke patients during 
Lokomat walking compared to overground walking and of a group of able-bodied 
subjects during overground walking (chapter 2). Chapter 3 reports whether exercise 
intensity during Lokomat therapy is potentially adequate to elicit a cardiorespiratory 
training effect in patients after stroke. Furthermore, in chapter 3 the question of how 
assistance during walking in the Lokomat affects this exercise intensity is addressed. 
Subsequently, chapter 4 contains the evaluation of the effectiveness of the Lokomat 
in improving walking ability in non-ambulatory stroke subjects involved in inpatient 
rehabilitation, and in chapter 5 we examined associations between balance and 
strength of these stroke patients. Chapter 6 shows whether robot-assisted gait 
training induces sufficiently high intensity of exercise for patients with incomplete 
spinal cord injury to induce improvements in cardiorespiratory fitness. Furthermore, 
it describes whether patients improved their cardiorespiratory fitness during an 
intervention of a 24 session of walking in the Lokomat (chapter 6). In chapter 7, it is 
investigated whether patients with lesions of the spinal cord improve in ambulatory 
function, balance and mobility during an intervention with the Lokomat. Finally, in the 
discussion (chapter 8) of this thesis the main findings are summarized and a selection 
of methodological considerations in relation to the study design, selection of study 
populations and outcome measures are discussed, along with clinical implications 
and recommendations for future research.
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Robot-assisted walking versus 
overground walking in stroke patients: 
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ABSTRACT
Objective: There is increasing evidence that robot-assisted treadmill training might 
be useful for gait rehabilitation after stroke. The aim of this study was to evaluate 
the muscle activity of stroke patients during robot-assisted walking and overground 
walking, and of a group of able-bodied subjects during overground walking. 
Design: Case-control observational study.
Subjects: Ten stroke subjects and 10 able-bodied control subjects. 
Methods: Electromyography measurements of 7 lower-limb muscles were made 
in 3 trials: robotic walking in which stroke subjects walked in a robot-assisted gait 
orthosis; overground walking for the same group of stroke subjects; and overground 
walking for control subjects. Trials were compared with respect to electromyography 
amplitude of selected leg muscles.
Results: Higher muscle activity during overground walking compared to robotic 
walking was found in several muscles during several phases of the gait cycle. During 
the stance phase, activity of the gluteus medius and gastrocnemius muscles was 
significantly lower during robot-assisted walking compared to overground walking 
and a significant interaction effect (trial x leg) was found in the tibialis anterior muscle. 
During swing phase, activity of the semitendinosus and tibialis anterior muscles were 
significantly lower during robot-assisted walking compared to overground walking.
Conclusion: Robot-assisted treadmill training may elicit lower muscle activity and 
changes in the muscle activation patterns during walking in some muscles.
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INTRODUCTION
As a result of stroke, patients often show a decrease in walking speed, stride length 
and cycle duration as well as an asymmetrical walking pattern,1,2 which reduces their 
ability to perform functional activities in daily living.3 Since improvement in walking 
ability is a major requirement for independence in daily functioning, improvement 
in gait function is an important goal during the rehabilitation of patients following 
stroke.4 
Robot-assisted walking devices have been used for a number of years during 
rehabilitation of stroke survivors for regaining and improving walking ability. The 
advantages of robot-assisted training, compared with manually assisted treadmill 
training, are suggested to be a longer training duration, reproducible gait kinematic 
patterns of the leg movements, hands-free operation by a single therapist, and 
reduction of the physical load imposed upon the therapist.5-7 However, to date, there 
is still no consensus regarding the evidence on the possible benefits of robot-assisted 
treadmill training. While some studies report similar or even better training effects 
when comparing robot-assisted treadmill training with body-weight supported 
treadmill training8,9 or other conventional therapies,10,11 others report the opposite, 
with less efficacy for robot-assisted therapy12,13 compared with conventional physical 
therapy. Nevertheless, a systematic review, published in 2007, suggests that stroke 
patients who receive electromechanical-assisted gait training in combination with 
physical therapy are more likely to achieve independent walking than patients 
receiving gait training without these devices.14 
One of the possible disadvantages of robot-assisted gait training may be the 
guidance of the device, potentially reducing the effort of the patient during training 
at high passive guidance.15 Another important disadvantage of robot-assisted 
training is the limited degrees of freedom of a robotic device restricting the walking 
pattern during robot-assisted walking (e.g. with the device used in the current study, 
one can only move in the sagittal plane in which pelvis motion is restricted). These 
restrictions may lead to deviations from a normal walking pattern, which can result 
in abnormal torque patterns,16 leading to altered muscle activity when using such a 
device compared with overground walking.17 For example, in able-bodied subjects a 
higher muscle activity of quadriceps muscles in the swing phase due to the restricted 
pelvis and a decrease in activity of the ankle flexors and extensors throughout the 
entire gait cycle as a result of the passive guidance has been reported.17 Because 
these differences attenuated when subjects were specifically instructed to maximize 
their effort, it seems that the passive guidance during robot assistance should be 
kept as low as possible.15 However, the above-mentioned findings are based only on 
studies on healthy subjects, while the actual training is meant for patients; it seems 
relevant to investigate whether these results can be generalized to a group of stroke 
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patients walking in the device. Therefore, the present study investigated muscle 
activity during robot-assisted treadmill walking in stroke patients. This muscle activity 
was compared with muscle activity during overground walking by the same stroke 
patients and by a group of able-bodied subjects.
METHODS
Subjects
After signing an informed consent, a group of 10 chronic stroke patients (6 men 
and 4 women, mean age 55 years (standard deviation (SD)11) with a left (n = 2) or right 
(n = 8) hemiparesis participated in the current study. The study was approved by the 
ethics committee of the VU University, Amsterdam. The hemiparesis was caused by 
an ischemic stroke in 5 subjects and by a hemorrhagic stroke in the other 5. The mean 
time since stroke was 65 (SD 47) weeks. Because the study aimed to compare robot-
assisted walking with overground walking, subjects with a functional ambulation 
category (FAC) score of 5 were selected, indicating that they were able to walk 
independently on flat surfaces, stairs and slopes without assistance. The patients 
received conventional physical therapy training prior to the study; however, subjects 
had no experience of walking in a robotic device. A second group, the control group, 
comprised of 10 able-bodied subjects (5 men and 5 women, mean age 47 years (SD 
12)) without any gait pathologies.
Study design
The group of patients after stroke participated in two measurement trials. 
During the robot-assisted walking trial (RW), subjects first performed a warm-up and 
underwent a familiarization protocol consisting of 10 min of robot-assisted walking 
with maximal body-weight support (BWS) and guidance force (GF). The warm-up 
phase was followed by a measurement period in which subjects walked in the robot-
assisted walking device at a constant walking velocity of 2.2 km/hour (which was a 
common speed at which inpatients normally walked during therapy), with minimal 
support in terms of GF and BWS equal for both legs. These minimal values were 
determined individually for each subject by gradually reducing both GF and BWS 
until self-reported maximal effort was reached. During the measurement, 60 s of 
muscle activity data were collected. After a 10-min break to prevent possible effects 
of fatigue, the RW trial was followed by an overground walking trial (OW) in which 
subjects walked without assistance at a self-selected normal walking speed, during 
which data were collected for 60 s. The control group performed a walking trial (CW) 
at a velocity matched to the RW trial (2.2 km/hour), during which data were collected 
for 60 s. The CW walking trial was performed using a regular treadmill (Forcelink, 
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Culemborg, The Netherlands) in order to control the walking velocity. 
Measurements
In this study, robot-assisted walking was performed using the Lokomat gait 
orthosis (Hocoma AG, Volketswil, Switzerland). This device consists of a motorized 
treadmill, a BWS system and two lightweight robotic actuators attached to the 
subjects’ legs to support the leg movements during gait, allowing GF, BWS and 
walking speed to be controlled. The orthoses of the Lokomat were adjusted to the 
subjects’ legs to ensure that the subject’s knee and hip joints were aligned with those 
of the Lokomat. Foot straps were used to prevent unwanted plantar flexion.
A 16-channel electromyography (EMG) recording system with surface electrodes 
(Porti, Twente Medical Systems International, Oldenzaal, The Netherlands) was 
used for measuring muscle activity of the following muscles: medial gastrocnemius, 
tibialis anterior, semitendinosus, rectus femoris, adductor longus, gluteus maximus 
and gluteus medius. These muscles represent the muscle groups covering the main 
functions of the lower limbs during gait. We measured EMG in both legs in the patient 
group and on the right leg in the control group. Heel strikes were determined by 
a foot-switch (Force Sensitive Resistor, MA-153, Motion Lab Systems, Los Angeles, 
USA) in all conditions. All OW trials of patients were captured on video (SIMI Reality 
Motion Systems GmbH, Unterschleissheim, Gemany).
 
Data analysis and statistics
EMG signals were sampled at 1 kHz, and high-pass filtered using a 4th-order 
Butterworth filter with a 20-Hz cut-off frequency to remove low-frequency artifacts. 
Data were subsequently rectified and low-pass filtered using a 4th-order Butterworth 
filter with a 5-Hz cut-off frequency. In all trials, 10 gait cycles were extracted from 
the collected EMG data and time-normalized to gait cycle duration. Subsequently, for 
each muscle, EMG patterns were computed, averaging the 10 individual gait cycles to 
a single gait cycle of the muscle activity for each subject per trial. Detailed analysis of 
the muscle activity patterns was performed by dividing the EMG signal into 7 phases 
of the gait cycle with percentages of duration of the gait cycle according to Perry 
(Table 1).18 The first phase starts with the initial contact during heel strike, as the 
end of the gait cycle was the subsequent initial contact of the same foot. Since it is 
assumed that during CW and RW a normal kinematic walking pattern in the sagittal 
plane is represented, these percentages were adopted to divide the time-normalized 
gait cycles into the different phases. A symmetric gait pattern in able-bodied subjects 
in terms of kinematics has already been shown in the eighties by Hannah et al.19 A 
more recent review has shown that when measuring muscle activity of the lower 
limbs in healthy subjects reducing the amount of data by measuring just one leg 
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is reasonable.20 However, since patients with hemiplegia after stroke by definition 
have an asymmetric kinematic walking pattern, these percentages could not be used 
during OW. Therefore, the time-normalized EMG signal was divided into 7 phases by 
means of video gait analysis (SIMI Reality Motion Systems GmbH, Unterschleissheim, 
Gemany). Furthermore, we broke the gait cycle up into stance and swing phase (Table 
1). The level of asymmetry of the stroke patients was assessed by calculating the 
stance time ratio (the stance time of the paretic limb divided by that of the normal 
limb). A ratio of one is assumed to reflect perfect symmetry, while a ratio deviating 
from one reflects gait asymmetry. 
Table 1. Percentages of the 7 phases of the gait cycle
Phase in gait cycle Percentage of gait cycle
Stance phase
Initial loading 0–10
Mid-stance 10–30
Terminal-stance 30–50
Pre-swing 50–60
Swing phase
Initial-swing 60–73
Mid-swing 73–87
Terminal-swing 87–100
Analyses of variance (ANOVA) were performed to investigate possible differences 
in muscle activity of the paretic and non-paretic muscles between OW, RW and CW 
during all phases. In case of a significant effect of trial, Bonferroni post-hoc tests were 
performed. For both stance and swing phase for all 7 muscles, repeated measures 
analyses of variance (with mixed factorial design) were performed to investigate 
the muscle activity of the paretic leg and the non-paretic leg muscles during RW 
compared to OW. All statistical analyses were performed using SPSS (version 17.0.1). 
For all tests, the level of significance was set at p< 0.05. 
RESULTS
During RW, subjects walked with a mean BWS of 45% (SD 22%) of their own weight, 
while the mean GF on both legs was 45% (SD 16). During OW, stroke patients walked 
at a mean speed of 2.8 (SD 0.5) km/h, while during RW the walking speed was set at 
2.2 km/h. Furthermore, during OW subjects had a stance time ratio of 0.90 (SD 0.20), 
tending to deviate from 1. 
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Detailed analysis of muscle activity during the 7 phases of the gait cycle showed 
higher muscle activities in the paretic semitendinosus, gluteus medius, gastrocnemius 
and tibialis anterior muscle and in the non-paretic rectus femoris, semitendinosus, 
gluteus medius and tibialis anterior muscle during phases of OW compared to RW 
(Figures 1 & 2). Lower muscle activities were only found in the paretic semitendinosus 
in the terminal stance phase of OW compared to RW. Furthermore, differences in 
phases of RW and CW were found in the paretic semitendinosus and the non-paretic 
semitendinosus and adductor longus and gluteus medius.
Figure 1. Mean muscle activity during robot-assisted walking (dark bars ) and overground 
walking of the paretic muscles ( grey bars ) and the control group (light bars ) during all 7 
phases of the gait cycle. Bars represent the mean values averaged over subjects, while the 
standard deviations are represented by error bars. *Significant difference between the 
overground walking and robot-assisted walking. +Significant difference between the control 
group and robot-assisted walking. IL: initial loading; MSt: Mid-Stance; TSt: terminal stance; PS: 
pre-swing; IS: initial swing; MSw: mid-swing; TSw: terminal-swing
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In the stance phase, average activity of the gluteus medius and gastrocnemius 
muscles was significantly lower during RW than during OW. Furthermore, for the 
tibialis anterior muscle an interaction between type of walking and leg was found 
during the stance phase; while activity in the paretic tibialis during RW was lower 
than during OW, the activity in the non-paretic tibialis anterior was higher during RW 
compared to OW (Figure 3). For the swing phase, significantly lower muscle activity 
was found for the semitendinosus and tibialis anterior muscles (Figure 4) compared 
to OW. 
Figure 2. Mean muscle activity during robot-assisted walking (dark bars ) and overground 
walking of the non-paretic muscles ( grey bars ) and the control group (light bars ) during 
all 7 phases of the gait cycle. Bars represent the mean values averaged over subjects, while 
the standard deviations are represented by error bars. *Significant difference between the 
overground walking and robot-assisted walking. +Significant difference between the control 
group and robot-assisted walking. Il: initial loading; MSt: Mid-Stance; TST: terminal stance; PS: 
pre-swing; IS: initial swing; MSw: mid-swing; TSw: terminal-swing
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Figure 3: Mean muscle activity during stance of the muscles of the paretic (black bars) and 
non-paretic (grey bars) during robot-assisted walking (RW) and overground walking (OW). 
+Significant interaction. *Main effect for type of walking
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Figure 4: Mean muscle activity during swing of the muscles of the paretic (black bars) and 
non-paretic (grey bars) during robot-assisted walking (RW) and overground walking (OW). 
+Significant interaction. *Main effect for type of walking
DISCUSSION
The aim of the present study was to investigate leg muscle activation during 
robot-assisted treadmill walking in stroke patients compared with that in overground 
walking by the same stroke patients and by able-bodied subjects. For stroke patients, 
lower muscle activities were found in different muscles during several phases of RW 
compared to OW (Figures 1 & 2). Higher muscle activity during RW was only found in 
one phase of the gait cycle in the semitendinosus muscle. Furthermore, we found a 
significantly lower amplitude in gluteus medius and gastrocnemius muscles during 
stance in RW compared to OW (Figure 3), and a lower activity of the semintendinosus 
and tibialis anterior muscles during swing phase in RW compared to OW (Figure 4). 
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Additionally, the analysis revealed an interaction effect for the tibialis anterior during 
the stance phase indicating a difference in effect of type of walking for the non-paretic 
and paretic leg (Figure 3). The lower muscle activity during RW compared with OW 
suggests a lower effort during RW than during OW in these muscles, probably due to 
support provided by the robotic device and possibly by the restrictions of the device. 
The significantly lower EMG amplitudes of the gastrocnemius muscle and the gluteus 
medius during stance phase of walking in the Lokomat may be caused by the body 
weight support. Moreover, the lower activity of the gluteus medius during stance is 
possibly an indication that less stabilization of the hip joint is required during stance 
phase of RW. The interaction effect of the tibialis anterior is difficult to explain. Based 
on Figures 1 & 2 the interaction effect for the tibialis anterior may be explained by 
more activity early during stance in the paretic leg during OW, possibly through 
prolonged higher activity during swing phase (Figure 1). During swing phase, lower 
activity of the tibialis anterior can be explained by the foot straps fixing the ankle 
joint during the swing. The lower activity of the semitendinosus during swing of RW 
compared to OW may be  due to the assistance of the orthoses during walking in the 
Lokomat. Moreover, the atypical pattern of the semitendinosus muscle activity was 
already demonstrated by Hidler.17
Comparison with previous findings
The lower muscle activity during robot-assisted treadmill walking compared with 
overground walking is in line with earlier findings of Israel et al.,15 who showed that 
a robotic gait orthosis stabilizes the body, reducing muscle activity in quadriceps, 
hamstrings, tibialis anterior and calf muscles in spinal cord injured subjects. The 
pathological gait in stroke patients is characterized by an increased co-activation, 
especially around the hip, knee and ankle joints.2 Despite the aim of the present study 
to reduce support during RW to a minimum, GF and BWS were reduced to only half 
of the full support in some subjects. This support may allow the patient to reduce the 
muscle activation and maybe the co-activation during RW compared with OW. This 
relatively high level of support needed by the patient in this study may be caused 
by the lack of experience in robot-assisted walking of the subjects. Furthermore, it 
should be noted that, in the present study, similar GFs were chosen for both legs. 
However, a feature of the robotic device is to apply different GFs on the two legs. The 
present finding can therefore be extrapolated only to training sessions in which the 
GF between the two legs is kept constant.
A previous study showed that muscle activity during walking in the Lokomat with 
100% GF led to change in the naturally occurring muscle activation pattern in healthy 
subjects.17 In the present study we can confirm this for some muscles. We found 
significantly lower activity in the non-paretic adductor longus, the gluteus medius and 
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the semitendinosus, in some phases during CW compared to RW, and a significantly 
lower activity the paretic semitendinosus during CW compared to RW (Figures 1 & 2). 
However, because EMG amplitudes are dependent on individual factors (such as skin 
conduction), our results should be interpreted cautiously. Nevertheless, the lack of 
significant differences in all phases may suggest that there is no systematic difference 
between EMG amplitudes between healthy and patient groups. The results suggest 
that walking in the Lokomat changes the naturally occurring muscle activation 
patterns during walking in some muscles. 
Partial body weight supported treadmill training for stroke subjects has been 
demonstrated to result in a more symmetric walking pattern.21 Practicing a more 
symmetrical gait pattern may be important to regain more symmetric gait, which is 
an important outcome measure in several studies on hemiparetic subjects (e.g. 22,23). 
Although the restoration of gait symmetry does not seem to result in restoration in 
functional walking ability,24,25 gait symmetry is positively related to local stability of 
walking,26 and gait pattern variability27 Nevertheless, allowing compensation during 
practice may also result in improvement in functional ability without normalized task 
execution, suggesting that symmetric walking should not be encouraged.The present 
findings do not confirm more symmetric muscle activity patterns during walking on 
a treadmill (during RW) compared to OW in stroke patients. This might be due to the 
severity of the impairments in the sample of patients participating in this experiment. 
The stroke subjects who participated in the current study showed a tendency to an 
asymmetric walking pattern, but were relatively moderately impaired compared to 
patients who are non-ambulatory early after stroke. It may be reasonable to expect 
that patients with more impaired walking ability, probably have more asymmetry 
during overground walking28 which may be ‘corrected’ by the assistance of the 
Lokomat, possibly resulting in more symmetrical muscle activity. This may explain 
why we did not find more symmetric muscle activity in this study.
The present results represent outcomes of a robotic device consisting of robotic-
driven exoskeleton actuators, which is just one approach to robotic walking. In the 
so-called end-effector approach of robotic walking devices,29,30 the subjects’ legs are 
not aligned to an exoskeleton, but only the feet are supported by moveable plates 
that passively move the feet in the swing and stance phase. In this approach legs are 
not restricted to the exoskeleton gait trajectory, possibly leading to other training 
effects compared with the ones during robot-assisted walking using an exoskeleton 
approach. In terms of muscle activity these end-effector devices have been shown to 
lead to muscle activity patterns comparable to those observed during overground 
walking in healthy subjects.31 In addition, a randomized controlled trial, published in 
2007, showed that robotic-assisted walking using an end-effector approach results in 
a significant improvement in gait abilities.32 The results of the present study cannot 
necessarily be generalized to all types of robotic devices.
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Methodological considerations
There are some characteristics of the present study that may have influenced 
the outcome of the study. The self-selected walking speed during OW was 0.6 
km/h higher than the walking speed in RW, despite the fact that the RW speed was 
carefully chosen. However, a study on able-bodied subjects showed no differences in 
muscle activity patterns during robot-assisted walking with walking speeds ranging 
from 1.5 to 2.7 km/hour.17 Another study found a proportional increase in muscle 
activity with an increase in walking speed in able-bodied subjects.32 However, these 
differences in muscle activity pattern between different walking speeds mainly affect 
the amplitude of EMG. Based on this, a reduction in the differences in walking speed 
between the different trials in our study could have decreased the overall difference 
in muscle activity between the trials. 
No randomization of the trials (i.e. RW and OW) was done in the current study; 
RW was always followed by OW. It can be argued that muscle activity patterns may 
therefore be biased. For example, patients might have been fatigued during the RW, 
which may have influenced the muscle activity patterns during the OW. Although it 
cannot be excluded that the differences in walking speeds between the RW and the 
OW trials may have led to biases in the present results, the possible effects of fatigue 
or learning during the trials, which may have biased the results, appear to be small, 
since the time of exposure to both trials was relatively short and the time of recovery 
between trials relatively long (10 min). 
In conclusion, the results of the present study showed that leg muscle activity 
of chronic stroke patients is lower in robot-assisted walking than in overground 
walking. Despite the relatively low effort during robot-assisted treadmill training, the 
training may have other advantages that might make it suitable for rehabilitation of 
locomotor skills after stroke; for example, the duration of training can be relatively 
long. These results may be relevant when explaining possible training effects of the 
current therapy and when developing training strategies. However, no conclusions 
concerning long-term effects of robot-assisted walking therapy can be drawn 
from the present study. Whether these results hold for subjects with more severe 
hemiplegic gait (i.e. lower FAC scores) and for training situations with other settings 
of body weight support and guidance is unknown. Future studies can therefore be 
directed to answering these questions.
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ABSTRACT
It has been suggested that aerobic training should be considered in stroke 
rehabilitation programs to counteract detrimental health effects and decrease 
cardiovascular risk caused by inactivity. Robot-assisted treadmill exercise (using a 
Lokomat device) has the potential to increase the duration of walking therapy relative 
to conventional overground therapy. We investigated whether exercise intensity 
during Lokomat therapy is adequate to elicit a training effect and how assistance 
during walking in the Lokomat affects this exercise intensity.
Ten stroke patients (54±9 yrs) walked in both the Lokomat and in a hallway. 
Furthermore, 10 nondisabled subjects (43±14 yrs) walked in the Lokomat at various 
settings and on a treadmill at various speeds. During walking, oxygen consumption 
and heart rate were monitored.
Results showed that for patients, exercise intensity did not reach recommended 
levels (30% HRR) for aerobic training during Lokomat walking. Furthermore, exercise 
intensity during walking in the Lokomat device (9.3±1.6 ml/min/kg) was lower than 
during overground walking (10.4±1.3 ml/min/kg). Different settings of the Lokomat 
only had small effects on exercise intensity in nondisabled subjects.
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INTRODUCTION
A large portion of patients with stroke initially has no walking ability and cannot 
walk independently because of hemiparesis and compromised balance. Moreover, 
a subgroup is not able to walk independently, even after a few months into the 
rehabilitation process. The inability of walking independently or being active 
has been suggested to lead to further deconditioning and is related to balance.1 
Secondary impairments, such as muscle atrophy and reduced aerobic capacity, have 
been reported and suggested to contribute to further functional declines in gait.2 
To counteract detrimental health effects and to decrease cardiovascular risk due 
to inactivity, it has been suggested that aerobic training should be considered in 
stroke rehabilitation programs.3-6 Although there are probably differences among 
approaches in different countries and different rehabilitation centers, both Kuys et al.7 
and MacKay-Lyons et al.4 showed that contemporary stroke rehabilitation programs 
in Canada and Australia did not elicit adequate exercise intensity for aerobic training.
In recent years, a device for robot-assisted gait therapy (Lokomat, Hocoma AG; 
Volketswil, Switzerland) was developed to automate body-weight supported treadmill 
training for severely disabled patients. The Lokomat consists of a treadmill with a 
body-weight support system and two robotic orthoses that guide the individual’s 
legs, allowing patients to walk for longer duration and making more repetitions 
possible during therapy.5 Several studies have investigated the effectiveness of the 
Lokomat in restoring walking ability.8-10 However, there is a lack of studies related 
to exercise intensity of Lokomat therapy and the potential for facilitating aerobic 
training in severely affected patients with stroke.
Walking in the Lokomat has been shown to increase oxygen consumption (V̇O2) 
above resting levels in patients and nondisabled subjects without experience walking 
in the Lokomat, indicating that walking in the Lokomat is not passive.11 It is, however, 
still largely unknown whether exercise intensity of walking in the Lokomat during the 
rehabilitation process of stroke patients is within levels of intensity for aerobic training 
as recommended by the American College of Sports Medicine.12 Furthermore, there 
is little knowledge about how assistance during walking in the Lokomat influences 
exercise intensity of walking. E.g., in severely affected patients, walking speed in the 
Lokomat can be much higher than during overground walking. From the literature 
it is known that walking at a higher speed requires more energy,13,14 and therefore 
one could expect exercise intensity to increase during Lokomat walking compared 
to overground walking. However, body-weight support has been shown to decrease 
V̇O2 during treadmill walking.15 Also, the Lokomat assists the legs during walking, 
potentially decreasing exercise intensity.16 Finally, during walking in the Lokomat, the 
position of the pelvis is held constant relative to the treadmill, thereby decreasing 
the horizontal propulsion force and at the same time decrease energy cost during 
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walking.14 Combined, these factors complicate predictions of effects of assistance on 
exercise intensity during Lokomat walking.
To improve our understanding of the exercise intensity of Lokomat walking 
during therapy, our primary objective was to investigate the exercise intensity during 
Lokomat therapy and compare this to exercise intensity recommendations of the 
American College of Sports Medicine. The second objective was to compare exercise 
intensity of walking in the Lokomat with normal overground gait in patients with 
stroke. Since patients can walk for longer duration in the Lokomat and the device 
provides assistance during walking, we hypothesized that patients with stroke 
walking in the Lokomat walked at lower exercise intensity than during normal gait. 
The third objective was to evaluate how different settings of the Lokomat affect 
exercise intensity during walking on the device. We hypothesized that with increased 
assistance, exercise intensity of walking in the Lokomat decreases.
METHODS
General design
Participants came to the laboratory to perform two experimental sessions: 
walking in the Lokomat and walking in a hallway. Nondisabled subjects performed 
one experimental session consisting of Lokomat walking and unassisted walking on 
a treadmill. We collected cardiorespiratory parameters during each walking session. 
Lokomat device
The design and control of the Lokomat has been reported previously.7 In this study, 
the LokomatPro device (Hocoma, Switzerland) was used with the LEVI bodyweight 
support system. In all trials for both patients and able bodied subjects, the LEVI 
bodyweight support system was activated. Three settings were manipulated during 
this study: speed, amount of body-weight support (BWS) and Guidance Force (GF), 
which is the amount of assistance of the robotic orthoses.
Subjects
Ten hemiplegic stroke patients (6 male and 4 female; 54 ± 9 yrs) and ten 
nondisabled subjects (6 male and 4 female; 43 ± 14 yrs) participated in the study. 
Patients had a first-ever stroke and had no unstable hypertension, no unstable 
cardiovascular problems, no severe skeletal problems or severe cognitive and/or 
communicative problems preventing the ability to follow verbal instructions. All 
procedures were approved by the local ethics committee and all subjects gave written 
informed consent before participation. Table 1 presents patient characteristics such 
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as age, sex, lesion side, and time poststroke. Functional limitations are described 
using the Functional Ambulation Category (FAC) and Berg Balance Scale (BBS). The 
FAC score is a 6-point measure for walking ability,17,18 FAC scores below 3 indicate 
dependent walking ability, while 3 indicates supervision needed. The BBS, developed 
to qualitatively asses balance, consists of 14 test items scored on a 5-point ordinal 
scale.19
All patients had already received therapy in the Lokomat for at least 7 times before 
the first measurements were performed. Eight patients had been training on the 
Lokomat as part of their inpatient treatment to improve walking ability. Two patients 
were asked to participate in the study after their discharge from the rehabilitation 
centre. Patients were, therefore, familiar with walking in the Lokomat and settings 
were fine-tuned to the patients’ capabilities. In this study, nondisabled subjects had 
at least two practice sessions of 30 minutes in the Lokomat to get familiarized to 
walking in the device with various combinations of speed, BWS and GF.
Table 1: Characteristics of patients 
Patient Age (yrs) Time post 
stroke (wks)
Side of 
lesion
Gender FAC BBS
1 53 10 L M 2 28
2 47 52 R M 3 35
3 43 79 R F 3 22
4 71 11 R F 2 14
5 53 25 L M 3 16
6 62 18 R M 2 17
7 64 12 R M 2 24
8 47 16 R M 3 44
9 49 12 R F 3 35
10 50 12 R F 2 24
Mean ± SD 54 ± 9 25 ± 23 2.6 ± 0.5 26 ± 9
General procedures 
We measured V̇O2 and heart rate (HR) as indices of cardiorespiratory responses. 
During the Lokomat and treadmill trials, we continuously monitored V̇O2 with an 
Oxycon Alpha (Jaeger Germany). During the overground trials of patients, an Oxycon 
Mobile lightweight portable spirometer (Jaeger, Germany) was used to measure 
V̇O2. This portable system was attached to the chest with a comfortable vest (1.1 
kg). We continuously monitored HR with an HR monitor (Polar RS400, Polar Electro; 
Kempele, Finland)
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Patients with Stroke
During the experiments, we strapped the paretic arm using an arm sling as a 
precaution to prevent shoulder pain. We measured baseline resting V̇O2 in the seated 
position for 3 min. After preparation for Lokomat therapy, patients walked in the 
Lokomat while we monitored V̇O2 and HR. Lokomat settings were the same as those 
used for the patients’ regular therapy settings and were individually optimized in 
such a way that they walked at a comfortable walking speed (CWS) with GF of the 
device kept at a minimum level and appropriate BWS without knee buckling during 
the stance phase. We used settings from previous therapy sessions as reference 
settings for the trials in the Lokomat and adjusted settings if necessary.
Before patients with stroke performed overground walking, we measured baseline 
resting V̇O2 during sitting at the start of the experiment for 3 minutes. Subsequently, 
patients were instructed to walk at a comfortable speed along a 20-meter walkway. 
A physical therapist walked closely behind the patients either for supervision or for 
assistance in maintaining balance. After 20 meters, patients turned and walked the 
walkway in the other direction. Patients walked for 6 minutes continuously before 
sitting down or until they needed to sit down because walking became too strenuous. 
All subjects walked with their usual aids for overground walking: a quad cane and an 
ankle foot orthosis. 
We averaged recorded V̇O2 and HR data over 60-s intervals. We determined V̇O2 
during rest (V̇O2rest), the highest V̇O2 during the session (V̇O2peak), and the average 
V̇O2 over the interval between the third minute and the third last minute of walking 
(V̇O2avg) during both Lokomat walking and during overground walking and expressed 
them in both absolute values and in metabolic equivalents (METs). We computed 
METs using the formula V̇O2/V̇O2rest. Variables associated with HR were the lowest 
HR during rest (HRrest), HR at V̇O2peak (HRpeak), and average HR (HRavg). 
We estimated exercise intensity using the Karvonen method, with the heart rate 
reserve (HRR) being the difference between HRrest and the age-predicted maximal 
HR, estimated using the formula HRmax=220-age. For the patient using beta-blocking 
medication (n=1), the formula was adjusted by HRmax-beta=0.85 x (220-age).4,20 We 
estimated exercise intensity by expressing the HR relative to HRR (%HRR).12 ACSM 
guidelines for sedentary/extremely deconditioned nondisabled adults recommend 
training at a %HRR of 30%-45%.12 Both HRavg and HRpeak were expressed as %HRR and 
compared to these recommendations.
Nondisabled Control Subjects
Since patients with stroke are not capable of walking in the Lokomat at any 
combination of settings possible, we studied the effects of settings of the Lokomat 
in nondisabled subjects only. Resting V̇O2 was measured during three minutes of 
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seated rest. Nondisabled subjects walked in the Lokomat at eight combinations of 
settings, similar to those used during rehabilitation of stroke patients. We set speed 
at either 1.7 or 2.2 km/h, GF at either 50 or 20 percent, and BWS at either 50 or 25 
percent of body weight, resulting in eight (2 × 2 × 2) different conditions. After the 
Lokomat trials, nondisabled subjects rested a few minutes. The nondisabled subjects 
subsequently walked on a treadmill performing 4 walking trials at different treadmill 
speeds (0.7 km/h, 1.1 km/h, 1.7 km/h and 2.2 km/h). All trials were performed for three 
minutes. We further analyzed minimal HR during rest (HRrest) and average V̇O2 and 
HR during the last minute of all the Lokomat and treadmill only trials. The formulas 
used to estimate %HRR were also used to determine exercise intensity in nondisabled 
subjects.
Statistical analysis
We tested data for normality using Shapiro-Wilk tests. We performed paired 
t-tests to investigate whether exercise intensity (as measured with V̇O2 and %HRR) 
of Lokomat walking was different from normal overground gait in patients. To study 
the effects of several combinations of settings of the Lokomat on V̇O2 or %HRR, a 
three-way repeated measures ANOVA was performed, with within factors BWS 
(25% or 50%), GF (20% or 50%) and speed (1.7 km/h or 2.2 km/h) on the Lokomat trials 
only. Furthermore, 2 ANOVAs tested whether there was a difference in V̇O2 or %HRR 
between trials performed at the same speed with or without the assistance of the 
Lokomat. In these two ANOVAs, four Lokomat trials were compared to the treadmill 
trial at the same speed, for 1.7 km/h and 2.2 km/h respectively. Post hoc analyses were 
performed using paired t-tests with Bonferroni correction when appropriate. 
To evaluate whether patients and nondisabled subjects responded in a similar 
manner to assistance of the Lokomat, we performed a two-way (mixed design) 
ANOVA on V̇O2 and %HRR data with a between-subjects factor ‘group’ (patients and 
nondisabled subjects) and a within-subject factor ‘mode of walking’ (Lokomat or no 
Lokomat). During the overground trial of patients, the average speed was 0.7 ± 0.2 
km/h. For comparison, the trials for nondisabled subjects included in this analysis 
were the trials with walking speed of 0.7 km/h for normal walking and the Lokomat 
trial with theoretically the least assistance of the device (settings 2.2 km/h, BWS 25% 
and GF 20%), since these trials were the most comparable to the trials performed by 
patients. Homogeneity of variances was tested using Levene’s test for homogeneity 
of variances. Finally, we performed a t-test to investigate whether V̇O2 during 
Lokomat walking was similar for the subjects groups. Probability values of less than 
.05 were considered significant. All analyses were performed using PASW v18.0 (SPSS 
Inc., Chicago, IL, USA) for Windows. 
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RESULTS
Exercise intensity of Lokomat walking for stroke subjects
Table 2 shows a summary of the characteristics of the trials performed by patients 
are shown. One of the ten patients showed an individual exercise intensity which 
was above 30%HRR. For patients, exercise intensity expressed in METs was within 
the range defined as light physical activity intensity for the lowest fitness level group 
according to ACSM guidelines.
All variables and differences were normally distributed. In patients, the peak V̇O2 
during overground walking (10.4 ± 1.3 ml/min/kg) was significantly higher than during 
Lokomat walking (9.3 ± 1.6 ml/min/kg), t(9) = 2.83, p < .02, mean difference 1.1 ml/
min/kg, 95% CI[0.2 1.9]. Correspondingly, HRpeak during overground walking (104 ± 14 
beats per minute [bpm]) was significantly higher than during Lokomat walking (92 ± 
12 bpm), t(9) = 2.59, p < .03, mean difference HR 12.4 pbm, 95% CI [1.5 23.2].
Table 2 : Performance parameters during oveground and Lokomat trials
Overground Lokomat
Velocitypeak (km/h) 0.7 (0.2) 2.1 (0.1)
BWSpeak (%) - 33 (9)
GFpeak (%) - 29 (6)
Endurance (sec) 5.1 (0.8) 26 (5)
V̇O2peak (ml/min/kg) 10.4 (1.3) 9.3 (1.6)
V̇O2avg( ml/min/kg) 9.9 (1.4) 7.8 (1.5)
HRpeak (bpm) 104 (14) 92 (12)
HRavg (bpm) 104 (13) 89 (13)
METS 2.8 (0.3) 2.1 (0.3)
%HRRpeak 38 (13) 25 (7)
%HRRavg 38 (12) 22 (7)
Effects of settings of the Lokomat on exercise intensity
For nondisabled subjects, Table 3 shows V̇O2 and HR during all trials with 
corresponding settings of the device. Average V̇O2 and HR values during different 
Lokomat conditions are very similar for all eight different settings (L1-L8) and for the 
normal gait trials (N1-N4). 
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Table 3: Settings with corresponding V̇O2 and HR during Lokomat walking (L1-L8) and treadmill 
only walking (N1-N4)
BWS Speed GF V̇O2 (ml/min/kg) HR (bpm)
Rest 3.7 ± 0.4 60 ± 8
L1 50% 1.7 km/h 50% 7.9 ± 2.6 76 ± 10
L2 50% 1.7 km/h 20% 8.4 ± 2.3 79 ± 9
L3 50% 2.2 km/h 50% 7.9 ± 1.7 78 ± 10
L4 50% 2.2 km/h 20% 8.4 ± 2.2 79 ± 13
L5 25% 1.7 km/h 50% 7.8 ± 1.4 77 ± 9
L6 25% 1.7 km/h 20% 8.9 ± 2.3 79 ± 9
L7 25% 2.2 km/h 50% 8.0 ± 1.4 76 ± 13
L8 25% 2.2 km/h 20% 8.2 ± 1.8 77 ± 12
N1 0.7 km/h 7.0 ± 1.0 72 ± 9
N2 1.1 km/h 7.1 ± 0.8 74 ± 10
N3 1.7 km/h 7.9 ± 0.7 76 ± 11
N4 2.2 km/h 8.6 ± 0.9 77 ± 12
The three-way (2 × 2 × 2) repeated measures ANOVA revealed a significant higher 
effect for lower GF on V̇O2 (F(1,9)=6.84, p<.03 η2=0.43) and HR (F(1,9)=8.57, p<.02, 
η2=0.49). When GF was set at 20%, mean V̇O2 is 0.57 ml/min/kg higher, (95% CI [0.08 
1.06]) and mean HR was 1.9 bpm higher (95% CI [0.4 3.4]) than during GF of 50%. 
Furthermore, there was a borderline significant interaction effect of BWS and speed 
in HR data, F(1,9)=5.20, p<.049, η2=0.37, indicating that when BWS was 50%, walking 
at 2.2 km/h elicited a higher HR compared to 1.7 km/h, whereas when the BWS was 
25%, walking at 2.2 km/h elicited a lower HR compared to 1.7km/h. However, the 
differences between means were small (e.g. maximal difference was 2.3 b/min), 
therefore the interaction effect had a small effect size. 
The ANOVA’s comparing trials performed at similar speeds (4 Lokomat trials and 
one treadmill only trial at 1.7 km/h or 2.2 km/h, respectively) comparable results. 
There were no significant differences in V̇O2 (F(2.6,23.8)=1.58, p>.05, η2=0.15) and HR 
(F(2.4,21.7)=2.83, p>.05, η2=0.24) between trials with walking speed of 1.7 km/h. V̇O2 
at this speed was 8.2 ± 1.7 ml/min/kg and HR was 77 ± 9 bpm. Similarly, at 2.2 km/h 
there were also no significant differences in V̇O2, F(1.9, 16.7)=1.25, p>.05, η2=0.12, and 
HR, F(4, 36)=0.92, p>.05 η2=0.09. V̇O2 at this speed was 8.2 ± 1.4 ml/min/kg and HR 
was 78 ± 11 bpm. This indicates that, although subjects were assisted by the Lokomat, 
exercise intensity was not different from normal, unassisted walking when walking 
at the same speeds.
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Exercise intensity during walking in patients vs. nondisabled subjects
As a group, patients had a significantly higher V̇O2 (9.8 ml/min/kg, 95% CI[9.0 10.6]) 
than nondisabled subjects (7.6 ml/min/kg, 95% CI[6.8 8.5]), F(1,18)=15.67, p<0.001, 
η2=0.47 (Figure 1) across different modes of walking. There was no significant 
difference between V̇O2 during Lokomat walking and normal gait for the whole 
group, F(1, 18)=0.36, p>.05, η2=0.002. There was, however, a significant interaction 
between ‘mode of walking’ and ‘group’, F(1, 18)=11.21, p<.005, η2=0.38. Results of the 
analysis for %HRR were similar, i.e. patients had significantly higher %HRR (31.4 %HRR, 
95% CI[27 36]) than nondisabled subjects (12.3 %HRR, 95% CI[8 16]), F(1,18)=45.40, 
p<.001, η2=0.72 (Figure 1). There was no significant main effect for ‘mode of walking’, 
F(1, 18)=2.80, p>.05, η2=0.13, but there was a significant interaction between ‘mode of 
walking’ and ‘group’ F(1, 18)=12.00, p<.005, η2=0.4.  These statistical results confirm 
what Figure 1 indicates: patients responded differently than nondisabled subjects with 
different types of walking, i.e., while patients showed a lower V̇O2 and %HRR during 
Lokomat walking, the nondisabled subjects showed higher values during Lokomat 
walking than during normal walking at 0.7 km/h. Subsequent analysis showed no 
significant difference in V̇O2 during Lokomat walking in patients (V̇O2 9.3 ± 1.6 ml/min/
kg) compared to nondisabled subjects (V̇O2 8.2 ± 1.8 ml/min/kg) t(18) = -1.36, p > .05, 
mean difference 1.0 ml/min/kg, 95% CI [-0.6 2.6], indicating that V̇O2 during walking in 
the Lokomat were similar for patients and nondisabled subjects.
Figure 1: V̇O2 and HRR during Lokomat walking and normal gait for both patients (grey) and 
nondisabled subjects (black).
DISCUSSION
In this study, we compared exercise intensity of walking in the Lokomat with 
exercise intensity of normal gait in both patients with stroke and nondisabled subjects. 
Results indicate that the exercise intensity in patients was below levels recommended 
by the American College of Sports Medicine for sedentary/extremely deconditioned 
nondisabled adults (30%HRR),12 i.e. the absolute minimum level. Furthermore, this 
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study shows that exercise intensity of walking in the Lokomat is lower than during 
normal gait in severely disabled stroke patients. To evaluate the effects of settings 
of the Lokomat, nondisabled subjects walked at various combinations of settings, 
and it was demonstrated that the influence of settings of the Lokomat on V̇O2 and 
HR is marginal. Finally, it was demonstrated that, when walking in the Lokomat is 
compared to overground walking, patients responded differently to assistance of the 
device than nondisabled subjects.
Exercise intensity of Lokomat walking for patients
Our study suggests that, based on the estimates of exercise intensity, the target 
training intensities (30%HRR) were not reached for most patients when walking in 
the Lokomat. Nevertheless, a recent study by Chang et al.21 showed that after only 
two weeks of intervention, a group of patients with stroke training in the Lokomat 
had a larger improvement of V̇O2peak as measured during an incremental exercise 
test than a group on control patients receiving conventional therapy. Note, however, 
that differences in recovery of function between groups might also be responsible 
for an increase similar to that observed by Chang et al.21 This confounding factor 
should be taken into account during exercise tests in the (sub)acute stroke patient 
population. Nevertheless, the advantage of Lokomat therapy is the longer possible 
duration of therapy. This may explain the findings of Chang et al.21 Furthermore, in a 
small randomized clinical trial, Huseman et al. reported an effect of Lokomat therapy 
on body tissue composition, which they suggested being due to increased aerobic 
metabolism.22 More research is warranted to study the effects of Lokomat therapy 
on cardiorespiratory fitness.
Effects of settings of the Lokomat on exercise intensity
Therapists have a range of settings to control during Lokomat walking. We only 
investigated the 3 main variables treadmill speed, body-weight support and amount 
of assistance.23 Krewer et al.11 demonstrated that using a lower BWS increased V̇O2 
when changed from 100% unloading to 30% BWS. Furthermore, they showed that 
neither speed nor GF had a significant effect on V̇O2. When compared to our study, 
lower levels of V̇O2 were found in Krewer et al.,11 which was probably due to other 
settings (e.g. lower speeds, or possibly other BWS system) or the better walking 
ability of patients in their study. In our study, we wanted to investigate the effect 
on V̇O2 and HR of various settings used during therapy. The observed significant 
effects were very small, therefore, it can be concluded that the effects of changing 
settings within the ranges used in this study are only small and the clinical relevance 
is therefore questionable.
Furthermore, for nondisabled subjects, exercise intensity of gait at 1.7 km/h and 
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2.2 km/h was similar for all trials performed at these speeds. We expected that the 
assistance of the device would decrease V̇O2 and HR relative to unsupported normal 
walking based on findings in the literature.15 The absence of such an effect may be 
explained by other factors that may have counterbalanced the assistance of the 
device, such as the requirement to follow a prescribed gait pattern. Wezenberg et 
al. showed that enforcing a normal step pattern increased metabolic energy cost of 
walking during treadmill walking.24 It seems plausible that similar mechanisms are 
responsible for the results in the present study.
Exercise intensity during walking in patients vs. nondisabled subjects
We found a difference in the way patients responded to the assistance of the 
Lokomat device compared to nondisabled subjects. Patients showed a lower V̇O2 and 
%HRR during Lokomat walking, whereas nondisabled subjects showed higher V̇O2 and 
%HRR during Lokomat walking than during normal walking at 0.7 km/h. These results 
are probably mostly due to observations already described in the literature25 that at 
similar speeds, hemiparetic walking is more energy demanding than nondisabled 
walking, with growing disparity with more affected hemiparetic gait. Figure 1 shows 
that the differences between exercise intensity of walking became smaller between 
subject groups when walking in the Lokomat was compared to normal gait. There 
was no significant difference between patients and nondisabled subjects during 
walking in the Lokomat. These findings confirm what Krewer et al.11 concluded, that 
for a given walking condition, patients performed similar as nondisabled subjects. 
This might indicate that cardiorespiratory responses of nondisabled subjects might 
be more similar to cardiorespiratory responses of patients during Lokomat walking 
compared to responses observed during overground walking.
Limitations of the study
Limitations of this study are the differences between patients in settings during 
Lokomat walking and the difference in overground walking speed for patients 
compared to nondisabled subjects. These differences may increase variability among 
subjects when patients are compared to the nondisabled subject group, and thereby 
decrease power of the statistics. However, when the two-way (2 × 2) factor ANOVA 
was repeated with data from the other Lokomat trials and the 1.2 km/h treadmill trial 
of nondisabled subjects (not shown), the results were the same as reported. The 
conclusion for the differences between patients and nondisabled subjects remains 
unaltered.
It is possible that the exercise intensity of Lokomat walking might still be 
somewhat higher with more sophisticated settings (such as asymmetrical settings) 
over the levels recorded in our study. By using voluntary efforts, exercise intensity can 
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also be increased as demonstrated by Jack et al.26,27 They showed that in incomplete 
patients with spinal cord injuries, V̇O2 can increase markedly when subjects actively 
push against the robotic orthoses while walking. It is unclear whether this can also 
be achieved by severely disabled stroke patients, however, it can be argued that the 
already altered muscle activity during walking in the Lokomat28 would be further 
changed. 
We instructed patients (and nondisabled subjects) to walk as normally as possible 
and follow the prescribed gait pattern. For severely affected patients, further 
decrease of the BWS and/or the GF will most likely not be possible because the 
prescribed gait pattern will not be followed properly; the precautions present in the 
Lokomat will intervene by stopping the device to immediate stand still when there 
is too much deviation from the prescribed gait pattern. Furthermore, walking with 
more challenging settings may not be perceived as comfortable and it remains to be 
seen whether patients are still capable and willing to walk for 20 minutes or longer at 
these more challenging settings of the Lokomat. 
The conclusions of this study do not necessarily extrapolate to other robot 
assisted devices. However, a few studies similar to our present study have been 
recently performed with a similar device,29,30 In line with the discussion above, these 
studies showed that only with the right settings it is possible to train patients at 
intensities sufficiently high for aerobic training effects.
Conclusions and recommendations
From this study it can be concluded that exercise intensity during Lokomat 
walking is light and below ACSM recommended values to improve aerobic fitness. 
Furthermore, changing settings within certain ranges prescribed and used for 
severely disabled patients has only a small influence on exercise intensity. 
Although our results suggest that the exercise intensity with Lokomat walking is 
most likely insufficient to elicit an aerobic training effect, there are indications that 
low-intensity training (at 30%HRR) may increase peak aerobic capacity,31 and that in 
stroke patients, Lokomat training might improve aerobic capacity21 and body tissue 
composition.22 These inconsistencies warrants further research to study the effects 
of training in the Lokomat on aerobic capacity and further investigation on how 
severely affected patients can exercise in the Lokomat at higher exercise intensities 
using other combinations of settings. 
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ABSTRACT
Background: Robot-assisted treadmill training with the Lokomat device has been 
used to improve walking ability in rehabilitation after stroke for more than a decade. 
This study investigates the effectiveness of the Lokomat in recovering walking ability 
in non-ambulatory stroke subjects involved in inpatient rehabilitation. 
Method: Thirty first-ever stroke patients completed 8 weeks of intervention. One 
group (n=16) received Lokomat therapy twice a week, combined with 3 times 30 
minutes a week of conventional overground therapy. The second group (n=14) 
received conventional assisted overground therapy only, during a similar amount 
of time (3.5 hours a week). The intervention was part of the normal rehabilitation 
program. Primary outcome measure was walking speed. Secondary outcome 
measures assessed other walking- and mobility-related tests, lower-limb strength, 
and quality of life measures. All outcome measures were assessed before and after 
the intervention and at wk24 and wk36 after start of the intervention. 
Results: Patients showed significant (p<.05) gains in walking speed, other walking- and 
mobility related tests and strength of the paretic knee extensors relative to baseline 
at all assessments. However, there were no significant differences in improvements 
in any of the variables between groups at any time during the study.
Conclusion: These results indicate that robot-assisted treadmill training is as effective 
as conventional training in recovering walking ability in non-ambulatory stroke 
patients.
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INTRODUCTION
Recovery of walking ability is one of the main goals during rehabilitation after 
stroke since it is an important factor in becoming independent in activities of daily life. 
Outcome of therapy is, however, still unsatisfactory in many cases, manifesting itself 
in decreased walking speed, asymmetric gait and decreased mobility compared to the 
healthy population.1,2 In practice, several types of therapy are employed to advance 
walking ability,3-5 such as overground gait training with assistance of a therapist or 
body weight supported treadmill training (BWSTT). In a Cochrane review, BWSTT 
was demonstrated to be no more effective than conventional overground therapy in 
improving walking ability.6 In search of more effective therapies, scientists, physicians 
and therapists have focused their attention on developing and using robot assisted 
therapy in the last decade.7 The theoretical advantage of robot assisted therapy is 
that it provides the opportunity to patients to start training early after their stroke, to 
practice walking longer and train with a more repetitive gait pattern.8-10
On the basis of results of pilot studies, there was substantial enthusiasm for 
the clinical use of these robot assisted devices.11 Presently, several devices, such 
as the Lokomat,12 are commercially available and other new devices are in the 
developmental stage (e.g. LOPES13). The Lokomat, developed to automate BWSTT 
for severely disabled patients, consists of a body weight support system and two 
robotic orthoses that guide the individual’s legs during walking on a treadmill.6,7 
When the present study was first initiated (Nov. 2008) there were only a few 
randomized controlled studies available in the literature on the effectiveness of the 
Lokomat.11,14,15 These studies reached conflicting conclusions on whether Lokomat 
therapy is more effective than conventional therapy in the rehabilitation after 
stroke. Therefore, setting up a new randomized controlled study (RCT) was deemed 
necessary. Presently, more randomized controlled studies have been published on 
the effectiveness of the Lokomat;16-19 Two studies found negative effects for Lokomat 
therapy,11,16 two studies reported beneficial effects14,17 and another three studies found 
no differences between therapy effects.15,18,19 Besides differences in patient population 
(in ability at baseline and time after stroke), one possible reason for these conflicting 
results may be that the amount of assistance of the orthoses during walking varied 
across studies; three of the studies used a fully enforced gait trajectory,11,16,18 three 
others allowed a decreased amount of assistance of the orthoses14,15,19 and one study 
did not reveal specifics about the amount of assistance.17 It is suggested that when 
using an enforced gait pattern, the effort level of patients might not be the highest 
because the Lokomat completely assists in the kinematic trajectory and therapy 
may therefore not be optimal.16 Furthermore, only two studies performed follow-
up measurements,11,16 both of which used a fully enforced gait pattern. If only short-
term effects are measured, important information about the ‘end-point’ of therapy 
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is missing. Currently, there is no study investigating both the short term intervention 
effect of the Lokomat using less guidance of the orthoses and the time course of 
further gains during a follow-up period.
The purpose of the present study, therefore, was to compare walking related 
improvements obtained after Lokomat therapy in combination with conventional 
overground therapy versus conventional overground therapy alone in stroke patients 
who were not able to walk independently. Secondary goals were to compare long 
term follow-up outcome measures and to investigate whether possible differences 
in recovery of walking ability between groups could be explained by changes in 
other outcome measures (e.g. differences in improvements in strength of the legs) 
and whether this would result in differences in amelioration of quality of life (QOL). 
We hypothesized that Lokomat therapy would elicit greater gains in walking ability, 
function, and mobility than conventional overground therapy aimed at recovery of 
walking ability with therapist assistance. Furthermore, we hypothesized that these 
improvements would be sustained at follow-up measurements.
METHODS
Initial sample size calculations based on an alpha of 5% and a power of 80% indicated 
that we needed 40 patients in each group to demonstrate a difference between 
groups in walking speed of 0.1 m/s seconds at wk10. Participants were recruited 
by screening admissions at Reade Center for Rehabilitation and Rheumatology in 
Amsterdam. Patients participating in the study had a first-ever supratentorial stroke. 
Other inclusion criteria were: hemiparesis, ≥18 years, inability to walk completely 
independently at start of the intervention, no unstable hypertension, no unstable 
cardiovascular problems, no severe skeletal problems or severe cognitive and/
or communicative problems preventing the ability to follow verbal instructions. 
All procedures were approved by the local ethics committee and all subjects gave 
written informed consent before participation. Patients were randomly (block 
randomization) assigned to either a robot-assisted therapy group or a conventional 
therapy group. The 8-week intervention consisted of 3.5 hours of physical therapy a 
week aimed at improving walking ability. The robot-assisted therapy group received 2 
hours of robot assisted treadmill training and 1.5 hours a week of conventional physical 
therapy aimed at recovery of walking ability (PT), whereas the conventional therapy 
group underwent 3.5 hours of PT. The therapy time aimed at walking was hence dose-
matched across the two intervention groups. Patients received the intervention as 
part of normal inpatient rehabilitation therapy (consisting of e.g. physical therapy 
for the upper limb, occupational therapy or speech therapy individualized for each 
patient). We chose this design because we wanted to investigate a design that was 
financially and practically feasible within the restrictions of the Dutch health care 
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reimbursement system. After the intervention period, patients received standard, 
but individualized rehabilitation therapy, either for a period of inpatient rehabilitation 
or a period of home-based rehabilitation.
Robot-assisted treadmill training
Robot-assisted treadmill training was administered using the Lokomat. The 
design and control of the Lokomat has been reported previously.12 In this study, 
the LokomatPro device (Hocoma, Switzerland) was used with the LEVI bodyweight 
support system. Three settings were manipulated during this study: speed, amount 
of body weight support (BWS) and the amount of assistance of the robotic orthoses 
(Guidance Force: GF). 
The first therapy session was used to adjust the device properly to the individual 
patient and allow the patient to get comfortable with walking in the device. In 
subsequent sessions patients were instructed to actively follow the walking pattern 
of the device. Initial speed was normally around 1.5 km/h at which speed we decreased 
the BWS up to a point where the patients were still able to support the weight on the 
legs during the stance phase without knee buckling. Simultaneously, we decreased 
the GF initially by 20%. As soon as we thought the patients had sufficient experience 
with the device, we activated the LEVI bodyweight support system and again made 
sure there was adequate BWS (i.e. no knee buckling). Using this system, weight 
support was regulated by a computer instead of a passive spring system. In following 
therapy sessions, we gradually increased speed (normally up to 2.5 km/h), decreased 
BWS (up to 10%) and decreased GF (up to 20%) in order to challenge the patient to 
walk as actively as possible with as little assistance of the device as possible. We used 
settings the patients were still able to walk with for about 20-30 minutes without 
getting exhausted. The ultimate goal was to walk at high but still comfortable speed, 
with as little BWS and GF as possible for as many minutes possible within the therapy 
time.
Assisted overground therapy
Overground assisted therapy (PT) was administered following guidelines of 
the Dutch Guidelines for Physical Therapy in patients with stroke 20, meaning that 
patients recieved assistance during walking of a therapist and assistive device(s) such 
as a cane or quad cane, horizontal bars or an ankle foot orthosis. 
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Outcome measures
Outcome measures were evaluated by assessors not blinded to treatment 
allocation of the patients. Primary outcome measure was walking speed at the 10m 
timed walk test assessed at baseline (wk1), at post-intervention (wk10), and at wk24 
and wk36 after start of the study. However, we only measured walking speed when 
patients had at least a Functional Ambulation Category (FAC) score of 2 (i.e. patient 
needed continuous or intermittent support of one person to help with balance and 
coordination). Since not all patients had this walking ability at baseline, especially 
during the early part of the intervention we were not able to measure walking speed 
in a group of patients. Walking speed was set to zero when patients had a FAC score 
below 2. 
Secondary outcome measures were also collected at baseline, at post-intervention 
and at wk24 and wk36 after start of the study. Outcome measures for walking ability, 
function and mobility were FAC, Berg Balance Scale (BBS), Motricity index (MI), 
Brunnstrom-Fugl-Meyer (FM), and Rivermead Mobility Index (RMI). For patients with 
a FAC≥3 we also measured ‘Timed Up and Go’ test (TUG). Furthermore, we measured 
maximal voluntary isometric torque of the knee extensors (MVText) and knee flexors 
(MVTflex) of both the paretic leg (P) and  the non-paretic leg (NP) using a custom-
built system 21 to investigate whether training in the Lokomat induced differences in 
lower-limb muscle strength. During the torque measurements, subjects were seated 
with a hip angle of 100º (180º being fully extended hips) and knee angle of 60º (0º= full 
extension) while the lower leg was strapped tightly to a force transducer. Movements 
of the leg and changes in hip and knee angles during force generation were 
minimized by tightly strapped hip and trunk belts to ensure isometric contractions. 
Finally, we assessed quality of life measures with the Short Form 36 (SF-36) and the 
Stroke Impact Scale (version 3.0, SIS 3.0). With these outcome measures we were 
able to determine improvements in walking ability, function and mobility, lower-limb 
strength, and quality of life measures.
Statistical Analysis
Group differences between the Lokomat and the conventional therapy in patient 
characteristics and baseline values for all outcome variables were analyzed using 
independent samples t-tests for continuous, normally distributed variables and 
Mann-Whitney U tests for categorical variables.
Since walking speed at baseline was not normally distributed because of the ‘zero’ 
walking speed of a number of patients (see Table 1), we used Mann-Whitney U tests 
to analyze the differences in the primary outcome variable walking speed between 
groups at baseline. Subsequently, at wk10, wk24 and wk36, changes in walking speed 
relative to baseline values were calculated. These change scores of walking speed 
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were analyzed using ANCOVA with correction for baseline values.22-24 The effect size 
for the differences in gains between groups was calculated using r.25
Secondary variables were analyzed similarly; we calculated changes in outcome 
measures by subtracting baseline values from the absolute values at each time point. 
Subsequently we performed ANCOVA with correction for baseline values on these 
change scores.22-24 Baseline values for TUG test were not available for the majority 
of the subjects (because TUG can only be performed when patients have FAC≥3), 
therefore change scores relative to baseline could not be calculated. Alternatively, 
we analyzed the available absolute TUG scores at each measurement using Mann 
Whitney U test in order to investigate between group differences in TUG. A p <.05 
was considered statistically significant. The effect size for the differences in gains 
between groups was calculated using r.25
All analyses were performed using PASW version 18.0. When parametric tests 
were used, means with standard deviation are reported. When non-parametric tests 
were used, median and interquartile range (IQR) are reported.
We were also interested in between-group differences in gains during the follow-
up period. Therefore, for all variables, we calculated the change scores relative to 
wk10 and analyzed the differences between groups in change scores during the 
follow-up period using ANCOVA with correction for outcome measures at wk10. 
RESULTS
Of the 37 patients enrolled in the study, 6 withdrew from the study within the 
intervention period because of a decline in health unrelated to the study (n=4), 
or refusal to further participate in the intervention due to pain (n=1) or fear (n=1). 
Furthermore, one patient was excluded from the study after randomization because 
location of the lesion had been incorrectly screened. Another 3 patients dropped out 
of the study before the first follow-up (wk24) because of travel limitations (n=1) or 
refusal to return for the measurements (n=2). One subject was not able to attend the 
follow-up measurement at wk24, but did return at wk36. At the last follow up (wk 
36), another 6 patients were lost: one patient had a second stroke, one patient was 
on vacation for 2 months, two patients refused to return for the last measurement 
and two patients had travel limitations. By the final measurement at wk36, 6 out of 
16 patients in the Lokomat group and 3 out of 14 patients in the control group had 
been lost to follow-up.
An interim conditional power analysis was performed based on the available 
data. This analysis revealed that in total 160 patients were needed to be recruited 
to demonstrate a significant difference in treatment effect (with alpha of 5 % and 
power of 80%). Since the time to recruit this number of patients was not available, 
we decided to stop the trial before the planned number of patients was recruited. 
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Table 1 shows characteristics of the patients and distribution of baseline measures 
of FAC scores per group. Of the 30 patients who completed the intervention 
period, 16 had been assigned to the Lokomat group, whereas 14 were assigned 
to the conventional therapy group. There were no significant differences in these 
characteristics between the groups at baseline.
Table 1: Patient characteristics and baseline (wk1) values for walking ability
Lokomat
(n=16)
Conventional 
(n=14)
p-value
Age (SD) in years 50.0 (9.6) 56.0 (8.7) .08#
Days post stroke (SD) 61.6 (28.7) 67.1 (49.1) .70#
Gender (M/F) 10/6 5/8 .29*
Side of stroke (R/L) 5/11 5/9 .80*
Ischemic/hemorrhagic 9/7 10/4 .40*
BMI (SD) 23.6 (3.9) 25.7 (4.0) .16#
FAC (0/1/2/3)§ -/8/5/3 2/6/4/2 .45*
* P value represents between-group comparison obtained with Mann Whitney U test. # P value 
represents between-group comparison obtained with t-test. § FAC=0: patient cannot ambulate/FAC=1: 
continuous physical assistance in support of bodyweight and balance required/FAC=2: continuous or 
intermittent physical assistance in balance required/FAC=3: supervision required.
Primary outcome measure walking speed
There were no significant differences (p=.93) in walking speed at baseline 
between Lokomat (0.03 m/s, IQR=0.14) and the conventional therapy group (0.00 
m/s, IQR=0.22). Patients had a significantly higher walking speed at all assessments 
relative to baseline (Table 2). However, there were no significant differences 
in improvements in walking speed between the intervention groups after the 
intervention period (wk10) or at the follow-up measures at wk24 and wk36 after start 
of the study (Figure 1, Table 2). Effect size ranged from 0.11 for the differences at wk10 
(post-intervention) to 0.25 for the differences at wk36 indicating a small to moderate 
effect. 
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Table 2: Secondary outcome measures: function and mobility
Measure (n per group: L/C) Lokomat Conventional Effect size (r) p-value† p-value‡
Walking speed (m/s)
baseline (16/14) 0.03 (IQR=0.14) 0.00 (IQR=0.23) .93* -
∆ wk 10 (16/14) 0.20 (0.16) 0.17 (0.17) 0.11 .57# .00
∆ wk 24 (14/12) 0.31 (0.27) 0.21 (0.21) 0.20 .34# .00
∆ wk 36 (10/11) 0.39 (0.30) 0.26 (0.21) 0.25 .28# .00
FAC 
baseline (16/14) 1.50 (IQR=1.0) 1.00 (IQR=1.00)  .45* -
∆ wk 10 (16/14) 1.25 (0.58) 1.29 (0.99) 0.00 .98# .00
∆ wk 24 (14/12) 2.00 (0.88) 2.00 (1.13) 0.02 .91# .00
∆ wk 36 (10/11) 2.60 (0.84) 2.27 (1.42) 0.22 .34# .00
BBS 
baseline (16/14) 16.0 (IQR=17.3) 11.5 (IQR=23.8)  .27* -
∆ wk 10 (16/14) 14.4 (9.5) 15.0 (9.6) 0.01 .94# .00
∆ wk 24 (14/12)  17.4 (14.7) 17.9 (10.2) 0.09 .64# .00
∆ wk 36 (10/11)  21.7 (12.2) 20.4 (12.0) 0.12 .60# .00
RMI 
baseline (16/14) 5.0 (IQR=2.8) 5.0 (IQR=2.3)  .40* -
∆ wk 10 (16/14) 3.8 (2.0) 3.8 (2.0) 0.05 .78# .04
∆ wk 24 (14/12) 5.8 (2.3) 5.6 (2.4) 0.02 .90# .00
∆ wk 36 (10/11) 6.5 (2.2) 6.1 (2.5) 0.13 .56# .00
FM leg 
baseline (16/14) 13.0 (IQR=7.3) 14.0 (10.3)  .69* -
∆ wk 10 (16/14)  2.6 (1.9)  3.1 (2.0) 0.13 .44# .03
∆ wk 24 (14/12)  2.6 (4.2)  4.0 (2.2) 0.10 .63# .02
∆ wk 36 (10/11)  4.0 (2.8)  5.4 (4.3) 0.15 .52# .01
TUG 
baseline (6/5) 63 (IQR=37) 70 (IQR=72) .47* -
wk 10 (15/10) 45 (IQR=27) 41 (IQR=38) 0.00 1.0* -
wk 24 (14/9) 47 (IQR=37) 42 (IQR=30) 0.08 .70* -
wk 36 (10/9) 32 (IQR=24) 37 (IQR=42) 0.20 .37* -
L/C: Lokomat/Conventional therapy group. † P value between group differences. ‡ P value change over 
time. * P value represents between-group difference obtained with Mann-Whitney-U test. # P value 
represents between-group difference corrected for baseline values obtained with ANCOVA. ∆ Indicate 
change in outcome measure from wk1, positive value means improvement.
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Figure 1: Average change (and SD) in walking speed relative to baseline at wk10 and at the two 
follow-up measurements wk24 and wk36.
Secondary variables
As shown in table 2, there were no significant differences in baseline values 
of FAC, BBS, RMI, FM leg and TUG between the Lokomat therapy group and the 
conventional therapy group. Patients significantly improved in all variables from 
baseline to wk10, wk24 and wk36 respectively. However, there were no significant 
differences in change scores for FAC, BBS, RMI, FM leg and TUG between the Lokomat 
therapy group and the conventional therapy group. Furthermore, there were also 
no significant differences between groups in gains during the follow-up period from 
wk10 to wk24 or from wk10 to wk36 for FAC, BBS, RMI, FM leg and TUG. Effect size 
ranged from 0.00 to 0.22 indicating small to moderate effects.
In table 3 the average values for the MVT measurements of both legs are shown 
for each group. Patients’ knee extension strength of the NP leg (MVTextNP), the knee 
flexion strength of the NP leg (MVCflexNP) and the flexion strength of the paretic 
(P) leg (MVTflexP) did not significantly change in the intervention period. The knee 
extension strength of the P leg significantly improved at wk10, wk24 and wk36 
relative to baseline. However, there were no significant differences between the 
Lokomat group and the conventional overground therapy group in changes in the 
MVT of the knee extensors or of the knee flexors of either leg. Effect size ranged 
from 0.08 to 0.30 indicating small to moderate effects.
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Table 3: Average MVT for knee extensors and flexors for the non-paretic as well as the paretic 
leg
Measure (n per group: L/C) Lokomat Conventional Effect size (r) p-value† p-value‡
MVTextNP (Nm)
baseline (16/14) 145 (42) 133 (37) .45º -
∆ wk 10 (16/13)    7 (21)     0 (15) 0.22 .26# 0.17
∆ wk 24 (11/10)   10 (29)   27 (24) 0.26 .26# 0.08
∆ wk 36 (9/5)   27 (20)   38 (48) 0.16 .58# 0.35
MVTextP (Nm)
baseline (16/14)   50 (IQR=46)   21 (IQR=39) .06* -
∆ wk 10 (16/12)    6 (20)   15 (15) 0.19 .31# 0.01
∆ wk 24 (11/10)   14 (29)   37 (29) 0.23 .30# 0.00
∆ wk 36 (8/5)   21 (23)   42 (36) 0.19 .53# 0.00
MVTflexNP (Nm)
baseline (16/14)   52 (23)   55 (19) .76º -
∆ wk 10 (16/13)    4 (13)  -3 (7) 0.29 .13# 0.30
∆ wk 24 (11/10)   10 (14)     4 (16) 0.21 .36# 0.11
∆ wk 36 (9/5)   14 (18)   7 (6) 0.23 .43# 0.66
MVTflexP (Nm)
baseline (16/14)   3 (IQR=7)   3 (IQR=7) .74* -
∆ wk 10 (16/13)    3 (6)    0 (3) 0.30 .11# 0.05
∆ wk 24 (11/10)    0 (7)    2 (8) 0.17 .45# 0.12
∆ wk 36 (8/5)    7 (9)    6 (5) 0.08 .79# 0.07
L/C: Lokomat/Conventional therapy group. † P value between group differences. ‡ P value change over 
time. * P value represents between-group difference obtained with Mann-Whitney-U test. ºP value 
represents between-group difference obtained with t-test. # P value represents between-group difference 
corrected for baseline values obtained with ANCOVA. ∆ Indicate change in outcome measure from wk1, 
positive value means improvement.
Table 4 lists the outcome of general health, social functioning, mobility and 
activities of daily life measured by the SF-36 and the SIS 3.0. The first 3 subjects were 
not assessed using the questionnaires, and some subjects were not willing to fill out 
the questionnaires, especially at follow-up at wk24 and wk36, resulting in additional 
missing values at follow-up. Therefore, in table 4 the results of the assessments 
using questionnaires are shown for the subset of patients for wk10 only. Patients 
significantly ameliorated in general health, social functioning, mobility and activities 
of daily life over the intervention period. However, we found no significant differences 
between groups in changes over time. Effect size ranged from 0.04 to 0.25 indicating 
small to moderate effects.
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Table 4: General health, social functioning, activities of daily life and mobility
Measure (n per group: L/C) Lokomat Conventional Effect size (r) p-value† p-value‡
SF 36: General health
baseline (12/12) 45 (IQR=23) 48 (IQR=24) 0.95*
∆ wk 10 (12/12) -0 (20) 8 (16) 0.25 0.25# .04
SF 36: Social functioning 
baseline (12/12) 19 (IQR=72) 25 (IQR=72) 0.79*
∆ wk 10 (12/12) 7 (32) 17 (36) 0.24 0.24# .00
SIS 3.0: Activities of daily life
baseline (12/12)* 34 (IQR=39) 38 (IQR=22) 0.91*
∆ wk 10 (12/12) 7 (21) 12 (18) 0.16 0.45# .00
SIS 3.0: Mobility 
baseline (12/12) 29 (IQR=34) 38 (IQR=33) 0.91*
∆ wk 10 (12/12) 10 (22) 9 (28) 0.04 0.86# .00
L/C: Lokomat/Conventional therapy group. † P value between group differences. ‡ P value change over 
time. * P value represents between-group difference obtained with Mann Whitney U test. # P value 
represents between-group difference corrected for baseline values obtained with ANCOVA. ∆Indicate 
change in outcome measure from wk1, positive value means improvement 
DISCUSSION
This study reports the results of a randomized clinical study on the effectiveness 
of an intervention with Lokomat therapy compared to conventional assisted 
overground therapy on the recovery of walking ability in non-independently 
walking stroke subjects in the Netherlands. During the course of this study, the 
primary outcome measure walking speed improved concurrently with secondary 
variables FAC, BBS, RMI, TUG, FM-leg, quality of life measures and knee extension 
strength of the paretic leg. These results are in line with literature demonstrating 
that changes in balance control and strength are associated with changes in walking 
ability.26 Furthermore, patients did not regain or improve the ability to generate 
knee flexion force of the paretic leg in the test position, or the strength of the non-
paretic leg. However, this study also shows that substitution of Lokomat therapy 
in the conventional rehabilitation program did not induce larger gains in any of the 
outcome measures than in conventional assisted overground therapy. Therefore, 
we reject our hypothesis that employing Lokomat therapy elicits greater gains than 
conventional overground therapy.
The lack of a difference in effect of the interventions might be partially explained 
by the moderate difference between the two interventions. Both groups received 
a total of 3.5 hours a week of physical therapy focused on walking ability. For 
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the control group, this consisted of 7 sessions of 30 minutes a week of assisted 
overground therapy, whereas for the Lokomat group this consisted of 2 session of 
one hour duration on the Lokomat combined with 3 sessions of 30 minutes a week 
of assisted overground therapy. During Lokomat therapy we decreased the amount 
of GF (assistance by the orthoses) of the legs as much as possible thereby eliciting 
more variability in stepping, which has been shown to be more effective than a fixed 
training trajectory in stepping rats.27 Although patients were upright relatively longer 
and walked faster during therapy in the Lokomat than during assisted overground 
therapy, the assistance of the device and the restrictions in possible movements16 may 
not have provided an equally suitable learning environment as during overground 
therapy. Apparently, the difference between intervention therapies was not sufficient 
to result in differences in gains in walking related outcome measures or in strength 
of the legs during the intervention period. Nevertheless, it may be possible that 
patients can be more effectively trained with different settings of the Lokomat (e.g. 
with more sophisticated settings such as asymmetrical loading of the legs). We only 
manipulated the 3 main variables, i.e. treadmill speed, BWS and GF. At present, there 
is no clear evidence available suggesting that certain settings are more effective than 
others. During the follow-up period, patients received standard individualized care, 
and it is therefore no surprise that the analyses of the follow-up measurements did 
not reveal differences between groups in gains either. 
Lack of power may be a concern in this study as the sample size is limited. 
However, effect sizes for the differences in gains for the intervention period were 
small for the difference between groups after the intervention period at wk10. In this 
regard it is interesting to note that effect size seems to be higher at follow-up. This 
could also be due to changes in the sample due to drop-outs. An additional analysis 
(not reported in results) with only the patients who completed the measurements at 
wk36 revealed that effect size (r) for the differences at wk10 in walking speed was 0.22 
indicating small to moderate effect. Possibly this is an indication that characteristics 
of the patients who dropped out of the study were different from the patient who 
remained included. However, analyses of the differences at baseline for time after 
stroke, walking speed, FAC, BBS, RMI and FM did not reveal significant differences 
between drop-outs and patients who completed the study.
Presently, seven randomized controlled studies have been published in literature 
on the effectiveness of improving walking ability using the Lokomat device after 
stroke.11,14-19 Westlake et al.18 and Horby et al.11 compared the effectiveness of Lokomat 
therapy with manually assisted treadmill training in a chronic group of patients 
(n=16 and n=48, respectively), whereas, Hidler et al.16 did the same for a sub-acute 
group of patients (n=63). Horby et al.11 and Hidler et al.16 found larger increments 
in walking speed and distance walked for the manually assisted treadmill training 
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group, whereas Westlake et al.18 did not find any differences in improvements. 
Another two studies reported an advantage of Lokomat therapy compared to 
overground therapy14,17 in terms of recovery of walking ability. Mayr et al.14 performed 
a small (n=16) quasi-experimental study (with mostly sub-acute patients, A-B-A or 
B-A-B design) and found larger gains in walking related outcome measures in the 
Lokomat phase of their study than in the overground therapy phase. Schwartz et 
al.17 performed a larger trial (n=67, all inpatient) and found that a significantly larger 
percentage of patients reached a FAC score ≥3 in the group of patients training with 
the Lokomat than in the conventional overground therapy group. Furthermore, 
Husemann et al.15 and Chang et al.19 did not find any differences in improvements 
in walking ability between Lokomat and conventional overground therapy in their 
studies (n=30, between 28-200 days after stroke, and n=37, within 1 month after 
stroke, respectively). Our study did not find any differences in gains in walking ability 
between Lokomat and conventional therapy, which is in line with results found by 
Husemann et al.,15 Westlake et al.,18 and Chang et al.,19 but not with those by Horby 
et al.,11 Hidler et al.,16 Mayr et al.14 and Schwartz et al.17 The apparent differences in 
conclusions of these studies may be due to differences in patient population (ability 
at baseline and time after stroke), differences in frequency of intervention or control 
therapy or differences in the type of assistance of the robotic orthoses. The results 
of studies that investigated the effects of Lokomat therapy using less then fully 
enforced gait pattern,14,15,19 are in line with results of several RCTs on the effectiveness 
of BWSTT training reporting similar or slightly more effect for BWSTT compared to 
overground therapy.28-31 
However, the overall evidence for a long-term superiority of improvement of 
walking ability by any intervention is presently rather weak. Unlike our study, many 
studies did not perform long-term follow-up measurements. Such long term follow-
up measurements are of utmost importance in studies on the effectiveness of any 
therapy after stroke. Several studies, such as the landmark publication of Duncan et 
al.,31 showed that patients can experience greater short term gains in walking ability 
shortly after stroke with intensive therapy (treadmill locomotor training) than with 
less intensive intervention. Also Veerbeek et al.32 showed, based on a meta analysis, 
that increased time spent on exercise of gait in the first 6 month after stroke results 
in greater improvement. However, it is also known that some patients show gains 
in walking ability even up till 1 year after stroke.33 Indeed, the LEAPS study results 
demonstrate that although a short term difference between effectiveness of therapy 
was found at 6 month after stroke, the extent of recovery of walking ability one year 
after stroke was not affected by intervention type.31 Presently, there are no studies 
that convincingly show that a particular intervention is better than others in the long 
run. Dobkin and Duncan34 therefore correctly concluded that there is no evidence 
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suggesting that BWSTT and robot assisted therapy provide clear advantages over 
conventional overground therapy. In future research on the effectiveness of therapy 
after stroke, study designs should include long term (e.g. >9 month) follow-up 
measurements, like in our study, to prevent possible premature conclusions about 
the effectiveness of a therapy. 
In conclusion, the clinical implications of the present study are that Lokomat 
therapy is an alternative for conventional overground physical therapy during the 
inpatient rehabilitation period for non-ambulatory stroke patients. For now, practical 
considerations, based on cost-effectiveness or pragmatic arguments, may direct 
decisions on whether to use the Lokomat or not in rehabilitation practice. Future 
research should point out whether robotic step trainers can perhaps be used more 
effectively (e.g. with other settings or assistance of the orthoses,35 or for particular 
subgroups of patients only), possibly in combination with other (experimental) 
therapies.36,37
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ABSTRACT
Objective: To study the association between recovery of maximal isometric knee 
extensor torque of the paretic leg (MVTp) or relative to the non-paretic leg (relMVT) 
and recovery of balance after stroke.
Design: a longitudinal observational study
Subjects: 23 stroke patients (time post-stroke: 10±6wks).
Methods: Berg Balance Scale (BBS), MVTp and relMVT were assessed at baseline 
(wk1), wk10 and wk24. Linear regression was used to study i) the association between 
BBS and MVTp or relMVT, and ii) the association between the change in BBS (ΔBBS) 
and the change in MVTp or relMVT (ΔMVTp or ΔrelMVTp) over the two intervals in 
the study period.
Results: BBS, MVTp and relMVT improved significantly (p<.05) over both intervals. 
The correlations between BBS and MVTp and between BBS and relMVT were of 
medium size [0.34-0.69] and seemed to be higher at later assessments. ΔBBS was 
significantly related to ΔMVTp and ΔrelMVT over wk1-wk10, but not over wk10-wk24. 
Conclusion: The association between balance and paretic knee extensor strength and 
the association between changes in balance and changes in paretic knee extensor 
strength is dependent on time of assessment. This may be due to differences 
between recovery mechanisms of balance and recovery mechanisms of paretic knee 
extensor strength.
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INTRODUCTION
After stroke, weakness of the leg contra lateral to the lesion is one of the most 
common deficits.1 Furthermore, balance and walking ability are affected, resulting in 
(a.o.) disturbed weight distribution during standing, disturbed equilibrium reactions 
and higher risk of falls during walking related activities.2-6 Over the past decade(s) 
emerging evidence suggests that weakness of the paretic leg is a major factor 
limiting performance of functional activities after stroke. For instance, in cross-
sectional studies, significant relationships have been found between weakness of the 
paretic leg and sit-to-stance ability, standing balance, and walking ability.3-7 However, 
these relationships are often assessed at an arbitrary moment in rehabilitation,8 
and therefore these studies ignore that the relationships between weakness and 
performance of functional activities may not be constant during the course of 
recovery after stroke. 
The relationships between weakness and performance of functional activities 
may imply that by reducing weakness, performance of functional activities improves. 
In literature, it is suggested that reductions in weakness may be realized by therapy 
(e.g.  resistance training) and may result in better performance of functional activities 
after stroke.1,7,8 The supposition of effectiveness of reducing weakness to improve 
performance of functional ability can be studied by relating changes in strength of the 
paretic leg to changes in performance of functional activities.7 Longitudinal studies 
in a cohort of patient during (early) rehabilitation will provide valuable information 
about the relationships between reduction of weakness of the knee extensors of the 
paretic leg and improvement of performance of functional activity. Such analyses 
of change scores have not been studied much before. In a prediction study, the 
changes in strength of the paretic leg have been reported to be longitudinally related 
to changes in walking ability for a group of stroke patients during the first 52 weeks 
after stroke.9 However, it is unclear whether there is a relationship between changes 
in weakness of the paretic leg and changes in performance of functional activities 
throughout the rehabilitation process. Knowledge about the time course of these 
relationships will add to our understanding of the relationship between weakness 
of the paretic leg and performance of functional activities and may help to optimize 
therapy during poststroke neurorehabilitation.
Many patients undergoing early inpatient rehabilitation cannot walk independently 
which make several tests recording performance of functional activities unsuitable. 
The Berg Balance Scale (BBS) seems a suitable alternative test of performance of a 
functional activity in this subgroup of patients because balance is important for many 
gait-related activities 10 and can be assessed in non-ambulatory patients. The first 
objective of this paper was to study the relationships between BBS and isometric 
maximal knee extensor strength of the paretic leg, measured at multiple assessments 
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during inpatient rehabilitation after stroke in a convenience sample of stroke patient. 
The second objective was to investigate the relationship between changes in BBS 
and changes in isometric maximal strength of the paretic knee extensors.
METHODS
Subjects and design
The present study was based on a randomized controlled trial investigating 
the effectiveness of robot-assisted walking compared to conventional therapy 
in improving walking ability and walking ability related outcome measures in non- 
independently walking patients during recovery after stroke (trialregister.nl, 
NTR3210). As we found no significant differences between groups in the effects on 
improving muscle strength, control of sitting and standing balance, or walking ability, 
we combined the patient profiles in one sample in the present longitudinal study. 
Patients entered the study after a first-ever ischemic or hemorrhagic hemispheric 
stroke. Main inclusion criteria were: no independent walking ability at start of the 
study, without cardiovascular problems, no other deficits in movement apparatus 
or severe cognitive and/or communicative problems preventing the ability to follow 
verbal instructions. All procedures were approved by the local ethics committee 
and all subjects gave their written informed consent before participation. The study 
design consisted of 4 measurements and started as soon as possible after admission 
in the rehabilitation centre (wk1). After this baseline measurement, all assessments 
were repeated at 10, 24 and 36 weeks after baseline assessment. 
Measurements
We chose the Berg Balance Scale (BBS) as a measure of performance of functional 
activities, because it can be assessed in patients undergoing early inpatient 
rehabilitation who cannot walk independently, in contrast to most walking ability 
measures. The BBS consists of 14 test items, scored on an ordinal five-point scale 
(0–4), with the scores of all items summed. Below a score of 45, stroke patients are 
relatively more at risk of falls during walking.1 BBS is a measure to assess dynamic and 
static ‘standing balance’.11 
We assessed the maximal isometric voluntary torque of the paretic knee extensors 
(MVTp) and of the non-paretic knee extensors (MVTnp) using a custom-built strength 
measuring device (Lower EXtremity System, LEXS), in which unilateral maximal 
isometric voluntary contractions of the knee extensors were performed (Figure 
1).4,5,12,13 Subjects were seated with a hip angle of 100 º (180º being fully extended 
hips) and knee angle of 60º (0º= full extension). The lower leg was strapped tightly 
to a force transducer (KAP, E ⁄ 200 Hz, Bienfait B.V Haarlem, The Netherlands, range: 
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0–2 kN) just above the ankle. The distance between the lateral femoral epicondyle 
and a fixed point at the force transducer was measured representing the external 
moment arm. A hip belt was fixed tightly to avoid changes in hip and knee angle 
during contractions and a trunk belt was used for stabilization. Subjects were asked 
to maximally generate isometric knee extensions for 2 to 4 seconds to determine 
maximal voluntary knee extension torque. After some practice attempts, at least 
two to a maximum of five successful attempts were allowed. Force was visualized in 
real time on a computer screen along with the maximum value achieved up to that 
trial. Subjects were encouraged to exceed their previously achieved maximal value. 
Maximal voluntary torque (Nm) was determined as the peak force (highest value of 
all attempts) multiplied by the external moment arm. 
Figure 1: Lower extremity system, with the white arrow indicating 
the location of the force transducer
Data analysis
Descriptive characteristics of the patients collected at baseline were reported 
as means with standard deviation (SD). Three observations of the isometric knee 
extension measurements were imputed by taking the average of the preceding and 
the following assessments; for one patient at wk 10 and for two patients at wk 24. 
The isometric strength of the paretic leg expressed in Nm, although often used in 
literature, does not account for inter-individual differences in maximal strength of 
the knee extensors. To correct for these inter-individual differences, we calculated 
the relative isometric knee extensor strength (relMVT) as the percentage of 
unilateral maximal isometric voluntary torque of the paretic leg (MVTp) relative to 
the unilateral maximal isometric voluntary torque of the non-paretic leg (MVTnp). 
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Subsequently we calculated the individual change scores (Δ-scores) for BBS and 
MVTp and relMVT. For a valid comparison at different assessment moments, the 
subject group needs to be the same for all measurements, i.e. we needed a complete 
data set. Because there was a substantial number of missing values for the last 
assessment (at wk 36, less than 50% of assessments was available) only the first three 
assessments were analyzed. Therefore, we only used the data of the 23 patients 
(out of 30) with a complete set of data for the first 3 assessments. Using paired 
t-tests, we studied whether BBS and strength scores (MVTp and relMVT) significantly 
changed over time. Using linear regression we calculated the regression coefficient 
for MVTp explaining BBS at each assessment. Similarly, linear regression was used to 
calculate the regression coefficient of ΔMVTp explaining ΔBBS over each assessment 
interval. The linear regression analyses were then performed again with relMVT and 
ΔrelMVT as the independent variable. We tested whether outcome variables were 
approximately normally distributed using Kolmogorov-Smirnov test. For all tests, a 
2-tailed significance level of .05 was used. All statistical procedures were performed 
using IBM SPSS version 20.
RESULTS
The Subject characteristics are shown in Table 1. Table 2 shows means and 
standard deviations as measured during the assessments at wk1, wk10 and wk24. 
BBS and MVTp were normally distributed at all assessments. BBS, MVTp and relMVT 
increased significantly over the interval of wk1-wk10 (p<0.000, p<0.011 and p<0.014 
respectively, Table 2) and wk10-wk24 (p<0.000, p<0.001 and p<0.001) respectively, 
Table 2). 
Table 1: Patient characteristics at baseline
Characteristic Total
Gender: women/men 11/12
Stroke hemisphere: left/right 15/8
Type of stroke (ischemic/hemorrhagic) 14/9
Age (± SD) (in yrs.) 54 ± 10
Time after stroke (in weeks ± SD) 10 ±   6
SD=standard deviation
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Table 2: Means and standard deviations at all assessments 
Wk1 Wk10 Wk24
BBS (± SD) 18 ± 11 33 ± 14 37 ± 15
MVTp (± SD) in Nm 39 ± 29 51 ± 29 64 ± 32
relMVT(± SD) in % 27 ± 18 34 ± 17 40 ± 18
Wk1-wk10 Wk10-wk24
ΔBBS (± SD) 14.3 ± 9.7* 4.2 ± 3.7*
ΔMVTp (± SD) in Nm 12.2 ± 21.1* 12.6 ± 15.4*
ΔrelMVT (± SD) in % 6.9 ± 12.5* 5.9 ± 7.7 *
BBS=Berg Balance Score, MVTp= knee extension strength of the paretic leg, relMVT= maximal isometric 
knee extension strength of the paretic leg relative to the non-paretic leg, SD=standard deviation, ΔBBS= 
change in BBS, ΔMVTp=change in MVTp, ΔrelMVT=change in relMVT, * significant improvement (p<.05)
Table 3 shows the coefficients of the linear regression models of BBS explained by 
MVTp at w1, wk10 and wk24 (Figure 2). The results indicate a significant relationship 
between BBS and MVTp at wk10 and wk24, but not at wk1. The size of the regression 
coefficient seems to increase over time and the correlation coefficients increase 
accordingly. The coefficient for relMVT show similar overall results. Moreover, the 
model with relMVT explains more variance in BBS than the model for MVTp.
Table 3: Linear regression models for BBS and MVTp at assessments wk1, wk10 and wk24
Dependent 
variable
Independent 
variable
Regression 
Coefficient
SE Correlation P-value
BBS at wk1 MVTp 0.130 0.077 0.344 0.108
BBS at wk10 MVTp 0.242 0.095 0.487 0.018
BBS at wk24 MVTp 0.306 0.079 0.646 0.001
BBS at wk1 relMVT 0.278 0.116 0.462 0.026
BBS at wk10 relMVT 0.479 0.155 0.559 0.006
BBS at wk24 relMVT 0.599 0.137 0.690 0.000
BBS=Berg Balance Score, MVTp= maximal isometric knee extension strength of the paretic leg, relMVT= 
maximal isometric knee extension strength of the paretic leg relative to the non-paretic leg, SE= 
standard error
Table 4 shows the coefficients of the linear regression models of ΔBBS explained 
by ΔMVTp and ΔrelMVT for the interval of wk1-wk10 and wk10-wk24 (Figure 2). The 
results indicate a significant relationship between ΔBBS and ΔMVTp over the interval 
of wk1-wk10, whereas there is no significant relationship over the interval of wk10-
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wk24. Similarly, the results indicate a significant relationship between ΔBBS and 
ΔrelMVT over the interval of wk1-wk10, whereas there is no significant relationship 
over the interval of wk10-wk24. 
Table 4: Linear regression models for ΔBBS and ΔMVTp over the intervals of wk1-wk10 and 
wk10-wk24
Dependent 
variable
Independent 
variable
Regression 
Coefficient
SE Correlation P-value
ΔBBS over wk1-wk10 ΔMVTp 0.248 0.085 0.537 0.008
ΔBBS over wk10-wk24 ΔMVTp -0.049 0.046 -0.226 0.299
ΔBBS over wk1-wk10 ΔrelMVT 0.347 0.152 0.446 0.033
ΔBBS over wk10-wk24 ΔrelMVT -0.101 0.092 -0.233 0.284
ΔBBS= change in BBS per week, ΔMVTp=change in maximal isometric knee extension strength of the 
paretic leg, ΔrelMVT=change in maximal isometric knee extension strength of the paretic leg relative to 
the non-paretic leg, SE= standard error
DISCUSSION
In this study we demonstrated significantly positive relationships between BBS 
and MVTp and between BBS and relMVT during rehabilitation after stroke. Moreover, 
we showed that these relationships were stronger at follow-up assessments. 
Furthermore, we showed that changes in balance (ΔBBS) were positively and 
significantly associated with changes in isometric maximal strength of the paretic 
knee extensors (ΔMVTp or ΔrelMVT) over the interval of wk1-wk10, but not over the 
interval of wk10-wk24.
Relationship between BBS and MVTp and between BBS and relMVTp
Our results are in line with literature suggesting that the maximal isometric 
strength of the paretic knee extensors is significantly related to patient’s ability to 
perform gait and gait related activities during the more chronic phases after stroke.14 
Moreover, it is in line with longitudinal studies, in which strength of the paretic leg 
was associated with balance and walking ability.11 The relationship between BBS and 
MVTp at wk1, however, was not significant. This non-significant relationship might 
be due to large variation between individuals in terms of maximal strength which 
were already present before the stroke (e.g. differences in height, sex or intrinsic 
strength generating capacity of the knee extensors). Indeed, when corrected for 
the inter-individual differences in absolute strength (or force/torque) of the non-
paretic leg by using the relMVT, we did find a significant relationship. Moreover, the 
model with relMVT also provides more explained variance indicating its superiority 
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over the model with MVTp. Our results also indicate that at follow-up assessments, 
the relationship between BBS and MVTp is stronger, which is in accordance with a 
study showing increases of the explained variance of walking speed by strength of 
the paretic leg at a follow-up assessment compared to that at the first assessment of 
the study.15 These findings can be explained by previously suggested mechanisms of 
recovery after stroke. First of all, the amount of individual reductions in weakness is 
related to the initial impairment.16 Secondly, it is commonly believed that reductions 
in impairment measures (like MVTp or relMVT) are associated with true recovery, 
whereas improvements in performance of functional activities (like BBS) are 
associated with true recovery, compensation strategies, or a combination of these.16 
Therefore, BBS will most likely improve relatively more compared to MVTp or relMVT. 
Consequently, at a follow-up assessment of the relationship (regression coefficient) 
between BBS and MVTp, the regression coefficient will be higher. Researchers need 
to take this into consideration in any study which relates strength measures with 
performance of functional activities measures. 
Relationship between ΔBBS and ΔMVTp or ΔBBS and ΔrelMVTp
The positive and significant relationship between ΔBBS and ΔMVTp or ΔrelMVT over 
the interval of wk1-wk10 are in line with literature showing that in rehabilitation after 
stroke, changes in strength of the paretic leg are longitudinally related to changes 
of walking ability.9 From a statistical point of view, we expected that the correlation 
coefficient between ΔBBS and ΔMVTp would be lower during wk10-wk24 compared to 
wk1-wk10 because we anticipated smaller changes over interval wk10-wk24 compared 
to wk1-wk10 with similar measurement error, thus obscuring the ‘real’ relationship. 
Indeed, we found no significant relationship between ΔBBS and ΔMVTp nor between 
ΔBBS and ΔrelMVT over wk10-wk24. However, since the improvements in strength 
of the isometric knee extensors were, contrary to our expectations, relatively large 
and the improvements in BBS over wk10-wk24 still significant other explanations for 
the change in the relationships between weakness and functional performance may 
be suggested. One explanation may relate to different mechanisms through which 
reductions in weakness and performance of functional activities are mediated in the 
two intervals. According to literature, early after stroke, structural changes occur in 
the brain due to spontaneous recovery.17 It is possible that over interval wk1-wk10, 
improvements in voluntary activation were the main mechanism responsible for the 
reductions in weakness, whereas over interval wk10-wk24, improvements in cross-
sectional area of the knee extensors may have occurred thus reducing weakness. 
Possibly, reductions in weakness due to improvement in voluntary activation are 
related to improvements in performance of functional activities, whereas reductions 
in weakness due to increased cross-sectional area are not, or less associated with 
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improvements in performance of functional activities. Alternatively, it is possible that 
inter-individual differences in how balance is learned, possibly through differential 
use of compensatory strategies to maintain balance have lead to the non-significant 
relationship between ΔBBS and ΔMVTp or ΔBBS and ΔrelMVT over wk10-wk24. 
Moreover, patients may have improved function in other muscles of the paretic leg, 
or patients may have improved in sensory function which might have resulted in the 
non-significant relationship between ΔBBS and ΔMVTp or between ΔBBS and ΔrelMVT 
over wk10-wk24. However, we do not have information about how strength of other 
muscles or sensory function has changed during this study, nor do we know whether 
the changes we observed in this study were therapy induced or spontaneous. 
Such analyses are useful in understanding the relationship between changes in 
impairments and changes in performance of functional activities. For example, it may 
be particularly useful in studying the effectiveness of improving strength through 
resistance training to improve performance of functional activities. Because we did 
not perform a strengthening intervention, this study does not provide indications on 
whether strength training should be performed during rehabilitation or not. 
In line with the literature we recognize that, in our study, time after stroke is an 
independent covariate for the amount of recovery after stroke.18 Preliminary analyses, 
however, only showed a significant correlation between time after stroke and MVTp 
at wk24, so we think we can be fairly confident that in our sample, time after stroke 
was not a major issue. We, nevertheless, recommend that to improve comparability 
of patients in terms of biological mechanisms of recovery, ideally, in future studies 
with similar goals, patients are enrolled in the study at the same time after stroke. 
Moreover, this may decrease the inter-individual differences, thereby improving the 
estimates of the models. 
Furthermore, in the analyses, ceiling effects should be considered, because it 
might be possible that patients reached the maximum test score for a particular test. 
In our study, results were probably not due to ceiling effects in the assessments tools 
used in this study as no patient reached the maximum possible BBS values before 
wk24. Another limitation of this study is that MVTp and relMVT are measures of knee 
extensor strength only, which, besides not differentiating between intrinsic strength 
capacity and the ability to maximally activate the knee extensors, obviously lacks 
information about other leg muscles in the paretic leg which also lacks the dynamic 
qualities of strength generation. Moreover, since individual patterns of recovery 
in terms of impairments and disability are heterogeneous, and are influenced by 
background variables of which some have been identified such as age9 or therapy 
intensity19 extrapolation of our results may be erroneous. Needless to say, general 
claims on the relationship between impairment and performance of functional 
activities for the whole stroke population based on our study should be made with 
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caution. Finally, the size of the sample and inclusion criteria of the patients limits 
generalizability to the general stroke population.
We conclude that the relationships between weakness of the paretic knee 
extensors and balance are not constant during the course of recovery after 
stroke, possibly due to compensation strategies during maintaining balance. Other 
relationships between variables measuring an aspect of weakness of the paretic leg 
and variables of performance of functional activities might show similar changes 
over time. Furthermore, apparently, reductions in weakness of the paretic knee 
extensors are not always associated with improvements in balance. Further research 
is necessary to investigate how the reductions in weakness of the paretic leg relate to 
improvements in performance of functional activities. For instance, it seems valuable 
to investigate how improved voluntary activation or improvements in cross-sectional 
area relate to improved performance of functional activities. We recommend that 
these future studies use analyses of the changes in the variables under study.
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The effect of robotic gait training 
on the cardiorespiratory system in 
incomplete spinal cord injury
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ABSTRACT
The objectives were to investigate the effect of robot-assisted gait training on 
cardiorespiratory fitness in subjects with motor incomplete spinal cord injury 
and to examine the exercise intensity of robotic walking and compare this with 
recommended guidelines. Ten patients followed a 24-session training program with 
a robotic gait orthosis in addition to physiotherapy sessions completed within 10-
16 weeks. Cardiorespiratory fitness was determined in a graded arm crank exercise 
test before and after the training program. To assess the intensity of robot-assisted 
walking, oxygen consumption (V̇O2) and heart rate (HR) were measured during a 
training session early in and at the end of the training program and exercise intensity 
measures (%V̇O2 reserve (V̇O2R), %HR reserve (HRR), Metabolic Equivalents (METs)) 
were calculated. Whereas no changes were found in peak V̇O2, the resting and 
submaximal HR at a constant work load were significantly lower after training. Most 
subjects exercised at low intensity (<30%V̇O2R, <30%HRR, <3.0 METs) and only two 
subjects exercised at moderate intensity (>3.0 METs). In spite of the low exercise 
intensity of the training program and no changes in peak V̇O2, robot-assisted gait 
training induced some improvement in cardiorespiratory fitness, as suggested by a 
lower resting and submaximal HR.
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INTRODUCTION
Physical inactivity is commonly reported in the spinal cord injury (SCI) population,1 
and is a major risk factor for developing cardiovascular disease (CVD).2,3 Being 
physically active can prevent CVD and a wide range of other medical conditions such 
as diabetes and obesity.4-6 Therefore, interventions to promote physical activity in 
the SCI population are becoming increasingly important. Traditional exercise modes 
to improve physical fitness for the SCI population are arm exercise in a wheelchair or 
using an arm ergometer and leg exercise with functional electrical stimulation (FES). 
However, the prevalence of shoulder pain, mostly as a result of overuse, is very high 
in wheelchair users.7-9 Therefore, an exercise modality without a repetitive use of 
upper extremities may be preferable. By using FES exercise, the large muscles of the 
legs can be activated which can lead to a wide range of fitness and health benefits.10-11 
However, about half of the population with SCI12 have incomplete lesions, which 
makes the application of FES painful for many of these individuals. As an alternative, 
robot-assisted gait training with the Lokomat was introduced13 as a form of aerobic 
exercise for these individuals with incomplete spinal cord injury (iSCI). 
The Lokomat is a device consisting of two robotic arms and a treadmill with a 
body weight support system. The robotic arms can be attached to the patient’s legs 
and the body weight is supported by a body weight support system while walking 
on the treadmill.14,15 Speed, body-weight support and amount of assistance can be 
adjusted to individual ability in order to create a challenging environment where 
patients can practice stepping. Most studies investigating robot-assisted gait training 
in iSCI focused on the effectiveness of improving neurologic and motor function and 
concluded that it is an appropriate therapy for improving walking ability.16-17 Although 
there is some knowledge with regard to the cardiovascular effects of body weight 
supported treadmill training with manual assistance,13,18-21 little is documented about 
the cardiorespiratory effects of robot-assisted gait training.
Promising results with regard to cardiovascular effects of robot assisted therapy22-25 
in SCI population have been reported. A recent cross-sectional study by Jack et al.24 
showed that, with vigorous active participation of patients, a substantial increase in 
heart rate (HR) and oxygen consumption (V̇O2) can be achieved. However, without 
the voluntary activity of the patient (i.e. passive walking) exercise intensity (HR 
and V̇O2) was much lower and probably insufficient to stress the cardiopulmonary 
system according to the levels of intensity for aerobic training as recommended 
by the American College of Sports Medicine (ACSM). Recently, by the use of more 
sophisticated controllers of the orthoses, gait patterns during robotic walking are 
less prescribed and more variation is possible. These new controllers allow active 
participation of patients in the kinematics of locomotion, which may be more effective 
for motor learning.26-27 However, the effects on the cardiorespiratory system have 
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not been studied yet. Furthermore, little has been documented about longitudinal 
changes in cardiopulmonary fitness by Lokomat therapy in SCI patients.13 Therefore, 
this study had two goals. The primary purpose of this study was to investigate the 
effect of a period of active robot-assisted gait training on cardiopulmonary fitness 
in subjects with a motor incomplete SCI. The secondary purposes of the study were 
to examine the exercise intensity of robotic walking and to compare this to the 
recommended guidelines for exercise intensity of the ACSM. 
METHODS
Subjects 
Ten subjects with a motor iSCI participated in this study (Table 1). The inclusion 
criteria were: paraplegia or tetraplegia as a result of a motor iSCI (ASIA Impairment 
Scale C, D28), minimum age of 18 years, height between 150 – 195 cm, maximum body 
mass of 115 kg. The limiting height and mass were necessary because of the design 
of the Lokomat device. The exclusion criteria were: medical complications, such as 
uncontrolled cardiac dysrhythmia and other unstable cardiovascular problems, severe 
skeletal problems such as osteoarthritis or recent fractures of the lower limbs, severe 
cognitive and/or communicative disorders, other neurological and/or psychiatric 
disorders, severe spasticity, open wounds or unhealed skin, thrombosis, pneumonia, 
other problems that make it impossible to accomplish the tasks. Information about 
the type and location of the lesion was provided by a clinical evaluation by a physician. 
After a detailed explanation of the purpose and the protocol of the experiments, 
all subjects signed an informed consent. The study was approved by the ethics 
committee of the VU University Medical Center Amsterdam. 
Study design 
A single-group pretest-posttest design was used to investigate whether 
cardiorespiratory fitness improved during the course of an intervention with robot-
assisted gait training and additional physical therapy. This pretest-posttest trial is 
used to assess possible effects of this intervention, as it is an essential step before 
setting up a randomized control trial.29 Cardiorespiratory fitness was evaluated using 
a graded arm crank exercise test performed at baseline and immediately after the 
training program. To examine the intensity of the training program, V̇O2 and HR were 
measured during a training session at the start and at the end of the training program.
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Table 1. Subject characteristics at baseline.
Subject ID Sex Age 
(years)
Height 
(cm)
Body mass
(kg) 
Lesion level Time post-
injury (years)
ASIA  LEMS
C1 M 52 185 79 L1 - L2 9 C 11
C2 F 31 161 50 T9 - T10 17 C 25
C3 F 44 170 96 T8 35 C 12
C4 M 35 173 76 T5 1 C 19
C5 F 33 166 63 C5 - T1 <1 C 13
C6 F 60 173 78 T4 5 C 10
D1 F 67 172 73 T1 - C1 8 D 41
D2 M 64 168 114 C5 - C6 <1 D 50
D3 F 34 172 60 T7 8 D 31
D4 M 63 180 83 C3 5 D 44
Mean 49 172 77 26
SD 14 7 17 15
SD = standard deviation, M = male, F = female, ASIA = American Spinal Injury Association Impairment 
Scale,28 LEMS = Lower Extremity Motor Score. 
Training program 
The training program consisted of 24 training sessions with a Lokomat device 
(Hocoma AG, Volketswil, Switzerland) with additional physical therapy sessions 
completed within 10 to 16 weeks. Training sessions were performed two or three 
times per week with at least one day of rest between two sessions. Each robotic 
training session lasted 60 minutes and contained 20 to 40 minutes walking time. 
Subjects trained with an individually adapted walking speed, body weight support 
(BWS) and robotic support (guidance force (GF)) in a way that he/she was able to 
walk comfortably for about 30 minutes. Training settings were adjusted individually 
by optimizing BWS, speed and GF as long as the training settings were tolerated by 
the patient. The additional physical therapy sessions consisted of usual home-based 
therapy at a local physical therapy practice or therapy in the rehabilitation center, 
which focused mainly on walking ability. This additional physical therapy was not 
protocolized. 
Arm crank exercise test 
Each subject performed a discontinuous progressive graded exercise test 
on an Angio arm ergometer (Lode BV, Groningen, The Netherlands) to assess 
cardiorespiratory function. The exercise tests were carried out by an experienced 
researcher. Subjects were asked to avoid food/caffeine/alcohol intake 2 hours prior 
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to the exercise tests. Before the exercise test, resting values for V̇O2 and HR were 
measured during five minutes of seated rest. In recorded test data, there were no 
signs of hyperventilation or signs for abnormal electrocardiogram (ECG).  The exercise 
protocol consisted of a minimum of three blocks of three-minute arm pedalling at 60 
rpm. The increase in work load was individually set by the researcher such that subjects 
needed a minimum of three exercise blocks to reach their peak performance. The 
estimation was based on the exercise performance (HR) of the first exercise block. 
One minute of rest after each block was included to facilitate the measurements for 
an additional study (recordings of the ECG and impedance cardiogram (ICG), see 
Meijer et al.30). Subjects were verbally encouraged to exercise to exhaustion. The 
exercise test was ended when a subject was not able to continue pedalling at 60 rpm 
due to exhaustion or when the subject indicated that he/she wanted to stop.  During 
the whole exercise test, V̇O2 was continuously monitored with a spirometer (Oxycon 
Alpha or Oxycon Mobile, Jaeger, Bunnik, The Netherlands) to measure V̇O2. V̇O2 was 
measured breath-by-breath and averaged over 5-s intervals. Throughout testing, HR 
was monitored by a Polar sport tester (Polar RS400/Polar RS800 and Polar WearLink 
belt) with a 5-s recording rate. In cases the Polar sport tester provided incorrect values 
of heart rates due to technical problems, the recorded ECG was used to calculate the 
proper heart rates. Pre- and posttest were executed following the same procedure. 
An example of the experimental setup of the exercise test is depicted in Figure 1. 
Figure 1: Experimental setup of the arm crank exercise test (left) and of the tested training 
sessions (right).
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Robotic walking tests
The first measurement was performed during one of the early therapy sessions 
(6th, 7th or 8th) when patients had become accustomed to walking in the device. 
The last measurement was performed during the 23rd or 24th training session. The 
timing of assessment was predominantly based on practical reasons (e.g. availability 
of subjects and measuring equipment). During both measurements, V̇O2 and HR were 
measured in the same way as during the arm crank exercise test. Prior to the training 
sessions, resting values of V̇O2 and HR were measured during five minutes of rest in a 
sitting position. The experimental setup is depicted in Figure 1. The procedure of both 
tested training sessions was as follows: 
1. Subjects performed a 5-10-min warm up to familiarize with the equipment and to 
warm up the legs.  
2. Part 1: walking at an individually standardized walking condition 
During the first part of the training session, individually adapted walking speed, 
BWS and GF were kept constant for at least four minutes to obtain steady state 
values for V̇O2 and HR. During both tested training sessions, the individually 
standardized walking settings of the robotic support were identical for each 
subject. 
3. Part 2: exercise intensity of robotic walking
During the last part of the training session, walking speed, BWS and GF were 
adjusted in a way, representative of a regular training session at that moment, to 
measure the exercise intensity. 
Outcome measures cardiorespiratory fitness 
Nine outcome measures were used from the graded arm crank test. Resting V̇O2 
and resting O2 pulse (V̇O2rest,and O2pulserest, respectively) were determined as the 
average over the last 60 seconds of quiet sitting. Submaximal V̇O2 and submaximal O2 
pulse (V̇O2submax, and O2pulsesubmax, respectively) were determined as the average 
of the last 30 seconds of block two of the arm crank exercise test. During this second 
block, subjects exercised at a submaximal intensity with a constant work load. Peak 
V̇O2 and peak O2 pulse (V̇O2peak,and O2pulsepeak, respectively) were determined as 
the average of the last 20 seconds of the last block of the arm crank exercise test. 
Furthermore, the lowest obtained heart rate during five minutes of seated rest was 
used as HRrest, submaximal HR (HRsubmax) was determined as the average of the last 
30 seconds of block two and peak HR (HRpeak) was the highest heart rate found in 
the last block. O2 pulse as a measure for cardiovascular efficiency was determined 
according to the following equation 1: 
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O2 pulse (ml/beat) = 
oxygen uptake (ml/min)
(1)
heart rate (bpm)
A higher O2 pulsesubmax after the training programme would therefore indicate an 
improvement in cardiovascular efficiency. Changes in submaximal V̇O2 (V̇O2submax) at 
a given workload would reflect changes in mechanical efficiency (for example due to 
better coordination of arm muscles).
Outcome measures robotic walking intensity 
Nine outcome measures from the robotic walking trials were used for analysis. 
Resting V̇O2 (V̇O2rest_robot) was determined as the average of the last 60 seconds 
during seated rest. Resting HR (HRrest_robot) was determined as the lowest obtained 
heart rate during sitting. Furthermore, the average of values over ten minutes of 
robotic walking during the last part of the training session were determined (V̇O2robot 
and HRrobot). Finally, steady state values of V̇O2 and HR (V̇O2std, HRstd), measured 
during the standardized robotic walking task, were calculated by averaging the 
last 60 seconds of walking at the specific standardized walking condition. V̇O2robot 
measures were expressed as a percentage of oxygen uptake reserve (%V̇O2R)31 and 
metabolic equivalents (METs)31 and HRrobot was expressed as a percentage of heart 
rate reserve (%HRR).31 The %HRR, %V̇O2R and METs were used as measures for the 
exercise intensity of the training program and were calculated by using the following 
equations (2 – 4):
% HRR = 
HRrobot - HRrest  * 100 (2)
HRpeak - HRrest
%V̇O2R = 
V̇O2robot - V̇O2rest  * 100 (3)
V̇O2peak - V̇O2rest
METs = 
V̇O2robot (4)
V̇O2rest
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Subsequently, the obtained %HRR, %V̇O2R and METs were compared with exercise 
intensity recommendations for sedentary people.31 ACSM guidelines for sedentary/
extremely deconditioned able-bodied adults recommend training at an intensity of 
30 - 45 %HRR or % V̇O2R in order to maintain or improve physical fitness. 
Statistical analysis 
After checking if the data followed a normal distribution, paired t-tests were used 
to determine if there were significant differences in resting, submaximal and peak 
V̇O2, HR and O2 pulse between both arm crank tests or between both tested training 
sessions. Means and standard deviations (SDs) were computed (but not all reported) 
for all outcome measures (Table 2; Table 3). Furthermore, the mean differences 
(with 95% confidence intervals) were also calculated. All statistical analyses were 
performed using SPSS version 19.0 for Windows. The significance level was set at 5%. 
Table 2: Mean and SD of resting, submaximal and peak values of oxygen uptake (V̇O2), heart 
rate (HR) and O2 pulse measured during both arm crank exercise tests (pre- and posttests). 
Outcome measures N Pretest Posttest Difference (post - pre)
Mean ± SD Mean ± SD Mean and 95% CI t-value p-value
Resting values 
V̇O2rest (mL·min-1) 9 247 ± 57 249 ± 61 2 (-29 to 33) 0.147 0.887
HRrest (bpm) 9 78 ± 14 71 ± 12 -7 (-12 to -1) -2.744 0.025*
O2pulserest (mL·beat-1) 9 3.0 ± 0.5 3.3 ± 1.0 0.3 (-0.2 to 0.9) 1.435 0.189 
Submaximal values 
V̇O2submax (mL·min-1) 9 750 ± 182 741 ± 209 -9 (-75 to 58) -0.304 0.769
HRsubmax (bpm) 9 116 ± 14 108 ± 14 -7 (-13 to -2) -3.359 0.010*
O2pulsesubmax (mL·beat-1) 9 6.5 ± 1.7 6.9 ± 2.1 0.4 (-0.3 to 1.1) 1.427 0.191
Peak values 
V̇O2peak  (mL·min-1) 9 1163 ± 407 1207 ± 402 44 (-120 to 208) 0.619 0.553
V̇O2peak  (mL·min-1·kg-1) 9 15.7 ± 5.1 16.5 ± 5.7 0.8 (-1.4 to 3.0) 0.835 0.428
HRpeak (bpm) 9 152 ± 26 151 ± 28 -1 (-9 to 7) -0.237 0.819
O2pulsepeak (mL·beat-1) 9 7.8 ± 2.1 7.5 ± 3.0 -0.3 (-1.8 to 1.2) -0.424 0.683
SD = standard deviation, 95% CI = 95% confidence interval, bpm = beats per minute, * = a significant 
difference (p<0.05) between pre- and post-values. 
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Table 3: Mean values (± SD) of oxygen uptake (V̇O2) and heart rate (HR) together with the 
exercise intensity measures determined during a training session at the start (first training) 
and at the end (last training) of the training program.
Measures N First 
training
Last 
training
Difference (last – first)
Mean ± SD Mean ± SD Mean and 95% CI t-value p-value
Robotic walking
V̇O2robot (mL·min-1) 10 536 ± 226 492 ± 203 -44 (-109 to 21) -1.54 0.159
V̇O2robot (mL·min-1·kg-1) 10 6.8 ± 2.2 6.4 ± 2.2 -0.5 (-1.3 to 0.3) 1.30 0.225
HRrobot (bpm) 10 94 ± 13 88 ± 10 -6 (-13 to 2) -1.73 0.118
V̇O2std (mL·min-1) 10 558 ± 267 453 ± 184 -105 (-215 to 4) -2.171 0.058
HRstd (bpm) 10 94 ± 16 84 ± 9 -10 (-19 to 0) -2.263 0.050
Exercise intensity 
%V̇O2R 8 23 ± 14 20 ± 13 3 (-9 to 3) -1.001 0.347
%HRR 7 23 ± 11 14 ± 11 8 (-16 to -0.4) -2.536 0.044*
METs 10 2.2 ± 0.9 2.1 ± 0.9 -0.1 (-0.4 to 0.1) -1.366 0.205
SD = standard deviation, 95% CI = 95% confidence interval, V̇O2robot and HRrobot = V̇O2 and HR during 
robotic walking, V̇O2std and HRstd = V̇O2 and HR during standardized robotic walking task, bpm = beats 
per minute, %V̇O2R = percentage V̇O2 reserve, %HRR = percentage of heart rate reserve, METs = V̇O2robot/
V̇O2rest, * = a significant difference (p<0.05) between both tested sessions. 
RESULTS
Arm crank exercise test 
One subject was unable to perform the arm crank exercise test due to inability 
to pedal with the device. Individual values of HRrest, O2pulserest, HRsubmax, O2 
ulsesubmax, V̇O2submax and V̇O2peak are depicted in Figure 2. Table 2 shows the resting, 
submaximal and peak values of V̇O2 (absolute and normalized for body mass), HR 
and O2 pulse measured during both tests. The t-test showed no significant difference 
in V̇O2submax  between pre- and posttest, but HRsubmax was significantly lower after 
the training program (Table 2; Figure 2). As a result of a lower submaximal HR at the 
similar submaximal V̇O2, O2pulsesubmax tended to be higher during the posttest. In 
line with submaximal values, HRrest was significantly lower at posttest compared to 
the pretest. 
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Figure 2. Individual values of resting HR (upper-left), resting O2 pulse (upper-right), submaximal 
HR (middle-left), submaximal O2 pulse (middle-right), submaximal V̇O2 (bottom-left) and peak 
V̇O2 (bottom-right) measured during both arm crank exercise tests (pre- and posttest). The line 
of identity (y = x) is also shown in the graphs. Resting and submaximal heart rate at posttest 
were significantly lower compared to pretest. No significant changes were found in resting O2 
pulse, submaximal O2 pulse, submaximal V̇O2 and peak V̇O2. 
Robotic walking
No changes were found in V̇O2robot and HRrobot between first and last tested 
training sessions (Table 3). Although not significant (p<0.1), almost all subjects had 
lower V̇O2std and HRstd during the standardized robotic walking task at the last 
training session compared to the first tested training session. Two subjects (D2 and 
D4) obtained their peak V̇O2 and HR during robotic walking instead of the arm crank 
exercise test. Therefore, it was not possible to calculate valid values for %HRR and 
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%V̇O2R of robotic walking for these subjects. Also, the %HRR of the last tested training 
session of subject D1 was excluded from the analyses, because during the whole 
training session, the heart rates of subject D1 were substantially higher compared 
to all other tests resulting in a much higher %HRR. For the remaining individuals no 
significant differences in %V̇O2R and METs were found between the start and the end 
of the training program (Table 3). However, %HRR was significantly lower at the last 
training session compared to first tested session. 
Individual results of %V̇O2R, %HRR and METs obtained at both tested training 
sessions are presented in Figure 3. Based on the %V̇O2R measured at the first tested 
training session, only subjects C3, C4 and D1 met the recommended guidelines of 
exercise intensity. During the last training session, subjects C3, D1 and D3 achieved 
a %V̇O2R above the minimum recommended value of 30% V̇O2R. In the same way, it 
is illustrated that at the start of the training program the %HRR of subjects C3, C6 
and D1 was above the recommended guidelines. At the end of the training program, 
only subject C3 exercised at an intensity above 30% HRR. V̇O2 during robotic walking 
was one to three times higher than V̇O2 at rest in most subjects. Only subject C3 and 
D4 achieved a METs-value above 3.0, which is considered as exercising at moderate 
intensity. V̇O2 during robotic walking of subject C5 was nearly the same as the resting 
V̇O2. 
Figure 3. Individual values of %V̇O2R (upper-left), %HRR (upper-right) and METs (bottom-left) of 
robotic walking during both tested training sessions. The black lines indicate the recommended 
exercise intensity according to the ACSM guideline.30 Most subjects exercised below this 
minimum level of exercise intensity. Dark bars indicate pretest, grey bars indicate posttest
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DISCUSSION
In this study, exercise intensity of walking in the Lokomat was investigated in 
subjects with iSCI. Results indicate that the exercise intensity in these patients was 
predominantly below recommended levels for sedentary persons on both assessments 
during the study. Nevertheless, based on the submaximal V̇O2 and HR values during 
the arm crank test, this study shows that cardiorespiratory efficiency/fitness might 
have increased during the intervention. The fact that there was no change in peak 
V̇O2 of the arm exercise test does not necessarily suggest that cardiorespiratory 
fitness did not improve after the training program. Peak V̇O2 determined during an 
arm exercise test is mainly limited by local factors (small muscle mass) rather than 
central factors (lungs or heart).32-34 Because the intervention was aimed at the legs, 
the exercise capacity of the arm muscle was assumed to be unchanged. Because of 
peripheral limitations, it is conceivable that the peak V̇O2 as measured during an arm 
crank test did not change while subject’s actual cardiorespiratory fitness did improve. 
Because of this limitation, we valued the submaximal values as more informative of 
whether cardiorespiratory fitness had improved. We used the arm crank test instead 
of a test using the lower limbs because we wanted to rule out the effect of possible 
improvements in neurological impairments in the legs elicited by the intervention. 
Such improvements would have the effect of an increased muscle mass being 
employed during the exercise test, which could lead to a higher V̇O2 that was not 
due to improvements in cardiorespiratory fitness. It appeared that after the robot-
assisted gait training, subjects had a significantly lower submaximal heart rate during 
arm crank exercise at the same work load and V̇O2. Although this suggests improved 
cardiovascular efficiency, we did not find a significantly lower O2 pulse. Furthermore, 
subjects had a significantly lower resting heart rate after a period of robot-assisted 
gait training, again suggesting an improved cardiorespiratory fitness. Although these 
results should be interpreted with caution, together these results indicate small 
improvements in cardiorespiratory fitness.
The improvements in cardiorespiratory fitness is rather surprising in light of 
the exercise intensity of the training program. The ACSM guidelines for exercise 
prescription,31 and Ginis et al.35 recommend that people with SCI should participate 
in an aerobic exercise activity of moderate to vigorous exercise intensity (30 - 60 
%HRR or 30 – 60 %V̇O2R or 3.0 - 6.0 METs) at least twice per week. The majority of 
the subjects, however, did not reach this minimum level and exercised at very low 
intensity (<20% V̇O2R or <20%HRR). In line with findings of the present study, Van 
den Berg et al.36 found that a low-intensity training program (30% HRR) can improve 
physical capacity in untrained able-bodied subjects. Especially for sedentary people, 
low exercise intensity seems to be safer and is associated with a higher motivation.37 
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In this light, robotic walking may be an attractive low-intensity exercise mode for 
people with SCI. 
Furthermore, the results showed that almost all subjects achieved lower 
submaximal V̇O2 and HR by performing the same robotic walking task after the 
training period suggesting an improved ability to employ the assistance of the device 
or an improvement in ‘robotic walking economy’.38 This improved ability to employ the 
assistance of the device or improvement in robotic walking economy might explain 
that most subjects had a lower %HRR at the end of the training program compared 
to the start. Furthermore, the average value of %V̇O2R was lower at the last training 
session suggesting that patients adapted to the training program. Although during 
every training session subjects were encouraged to contribute actively to the robotic 
walking activity, it was not always possible to reduce the robotic support in a way 
desirable, due to spasticity, risk of wounds and/or muscle weakness. This improved 
ability to employ the assistance of the device or improved walking economy was 
also observed in a study of the longitudinal changes in cardiopulmonary function 
during an intervention with robot-assisted gait training in two subjects with iSCI.38 
Nevertheless, contrary to our results, cardiorespiratory fitness did not improve in 
that study. The authors suggested that the improvement in robotic walking economy 
was mainly the result of a better gait pattern instead of changes in cardiopulmonary 
system. 
The average level of exercise intensity of robotic walking found in this study (2.2 
METs) was higher than found for passive walking in Jack et al.24 (1.4 METs), but lower 
than for ‘active’ walking in studies of Israel et al.23 and Hunt et al.39(2.5 and 4.0 METs 
respectively). Israel et al.,23 Hunt et al.39 and Jack et al.40 also presented values for 
peak V̇O2 (14, 16, 28 mL/kg/min, respectively) obtained during maximal active robotic 
walking that were substantially higher compared to values of the present study 
(V̇O2robot = 6.8 mL/kg/min). During active walking in these studies, patients were 
supposed to push against the orthoses with their legs while walking. When walking 
with less guidance force applied to the legs, such an instruction would probably 
lead to emergency stops of the device since safety limits will be surpassed. Another 
explanation for the difference in exercise intensity between our study and literature 
is the level of impairment, given that the legs can be loaded more when less impaired. 
In the studies by Israel et al.,23 Hunt et al.,39 and Jack et al.40 relatively more individuals 
with AIS D participated in the study than in our study. It is likely that the greater 
impairment of subjects in the present study has at least in part contributed to the 
lower exercise intensities found. Nevertheless, when subjects are encouraged to 
push against the orthoses of the Lokomat device during walking, as was done in Jack 
et al.,40 it seems conceivable that exercise intensity can increase.
Limitations of this study are the small sample size and heterogeneity of the study 
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population, the latter resulting in interindividual differences in the level of physical 
capacity and the differences of exercise intensity of the intervention. Furthermore, 
the %V̇O2R and %HRR were calculated with the use of the resting and peak values of 
V̇O2 and HR. Resting V̇O2 was determined after five minutes of quiet sitting, which, 
although commonly used, might not be optimal when assessing resting values.41 This 
might have resulted in overestimation of the resting values of V̇O2 and HR, which in 
turn results in underestimation of %V̇O2R and %HRR. On the other hand, the possibility 
exists that peak values of V̇O2 and HR were underestimated due to different factors 
such as subject’s motivation, day-to-day variations, the exercise protocol and exercise 
modality. For this reason, the %HRR of the last assessment of subject D1 was excluded 
from the analyses. Furthermore, it was not possible to calculate valid values of %V̇O2R 
and %HRR in two subjects (D2 and D4), because they obtained their peak V̇O2 and HR 
during robotic walking instead of during the arm crank exercise test. An alternative 
would be that peak HR would be estimated based on age. However, this could result 
in overestimation of the maximal heart rate, since individuals with spinal cord injuries 
above the level of T4 may have impaired sympathetic innervations of the heart. 
Therefore, we chose the method presented in this paper. To complement the results 
of the %V̇O2R  and %HRR we also calculated MET values. By comparing the V̇O2 and HR 
of both standardized robotic walking tasks, the assumption was made that external 
load was kept the same in both conditions. However, in this study the amount 
of hand rail support, which can influence the external load, was not completely 
standardized during both tests. Despite of this possible variation in external load, 
almost all subjects had a lower V̇O2 and HR at the last measurement compared to the 
first which still indicates an improvement in robotic walking economy. 
Conclusion
The majority of the subjects exercised below the minimum level of the 
recommended exercise intensity (<30%V̇O2R/HRR and <3.0 METs). In spite of the low 
exercise intensity of the training program and no changes in peak V̇O2 of the arm 
exercise test, the lower resting and submaximal HR suggest that a period of robot-
assisted gait training may have induced some improvement in cardiorespiratory 
fitness. However, because oxygen pulse did not show a significant improvement, 
likely improvements in cardiorespiratory fitness are small. Furthermore, almost all 
subjects had lower V̇O2 and HR during the same robotic walking task after the training 
period reflecting a higher robotic walking economy. Therefore, treadmill walking, 
including robot assisted walking, may not only help in improving walking ability, it 
might also have other secondary effects such as improvement in cardiorespiratory 
efficiency as found in this study. However, whether these effects are different from 
conventional therapy approaches may be studied in future randomized clinical trials.
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Recovery of walking ability using 
a robotic device in individuals with 
incomplete spinal cord injury
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ABSTRACT
Objective: To perform a pilot-study to investigate the effects of a moderately intensive 
program of locomotor training consisting of robot-assisted treadmill training using 
the Lokomat device combined with additional conventional therapy in patients with 
incomplete spinal cord injury (SCI).
Design: Repeated assessment of the same patients or single-case experimental A-B 
design
Setting: The inpatient and outpatient clinic of a rehabilitation centre in Amsterdam
Participants: Eighteen patients with motor or sensory incomplete SCI (7 patients <1 
year, 13 patients >1 year post-injury)
Intervention: One hour of Lokomat therapy was administered for 24 sessions within 
a period of 4 months with additional 30 minutes of conventional therapy. 
Outcome measures: Primary outcome measure was walking speed during 10-meter 
walk test. Other outcome measures were, Functional Ambulation Category (FAC), 
Timed Get up and go test (TUG), Walking Index for Spinal Cord Injury II (WISCI II), 
Hoffer Classification, Berg Balance Scale (BBS) and Rivermead Mobility Index (RMI). 
Results: Walking speed was significantly (p<.05) higher (on average .08 m/s) after the 
intervention compared to before the intervention. RMI also significantly improved 
during the intervention. Furthermore, we found a trend towards improvement in 
TUG and BBS. Other outcome measures (FAC, WISCI II, Hoffer classification) did not 
significantly change. Although at group level results were significant, there was quite 
some variation in the amount of improvement among subjects.
Conclusion: Walking speed may improve by this intervention in some patients, 
however, in most patients, gains in walking ability are small. 
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INTRODUCTION
The improvement of walking ability is an important goal during inpatient 
rehabilitation as well as during outpatient rehabilitation because even small gains in 
ambulation can make a meaningful amelioration of a patient’s daily life.1 In the last 
decade, gait training on a treadmill has been automated using robotic devices such 
as the Lokomat, a commercially available device.2 To date, there are only a limited 
number of studies that have investigated the effectiveness of Lokomat therapy. A 
few quasi- experimental studies have demonstrated improved walking ability after 
Lokomat therapy in individuals with acute or chronic, mostly incomplete spinal cord 
injury (iSCI).3-5 However, the authors of the three randomized clinical trials (RCTs) 
concluded that Lokomat therapy was not more effective than control therapies.6-8 
While these studies were ongoing, the controllers of the robotic orthoses of the device 
were improved making it possible to only partially assist the legs of patients instead 
of the original 100% guidance of the legs. The available randomized clinical studies in 
literature evaluate the effectiveness of Lokomat therapy with fully prescribed gait 
pattern only which may be lower than expected with more sophisticated control of 
the assistance in the gait pattern.9
In the Netherlands, because of limitations in the health care reimbursement 
system, only a limited amount of therapy is feasible. In current practice, this means 
that physical therapy is only possible for a limited number of therapy sessions each 
week. We investigated a training program outpatients could perform without too 
much interference with their daily life, and which could also be used for inpatient 
treatment. Currently, there are no studies reporting results of a study with a moderate 
(< 3 sessions a week) frequency of Lokomat therapy. Moreover, it is suggested that 
Lokomat therapy may be more effective when used in combination with overground 
therapy.10-13
The goal of this pilot study was to investigate whether walking speed and other 
gait related outcome measures would improve during an intervention in which the 
Lokomat device is used with more sophisticated settings with moderate frequency 
and additional conventional therapy a convenience sample of patients with iSCI. We 
hypothesized that patients would significantly improve their walking ability during 
the intervention period. 
METHODS
Patients were recruited from both the inpatient and outpatient clinic of a 
rehabilitation center in Amsterdam. Patients were asked to participate if they were 
older than 17 years, had stable blood pressure and had a motor or sensory incomplete 
lesion according to ASIA classification14 as a result of traumatic or non-traumatic 
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lesions of the spinal cord. Additionally, some sensory function needed to be intact 
in the legs. Exclusion criteria were: medical complications such as arrhythmias and 
unstable cardiovascular problems; severe skeletal problems such as osteoarthritis or 
osteoporosis of the lower limbs. All procedures were approved by the local ethics 
committee and all subjects gave written or oral (n=1) informed consent before 
participation.
Design
Patients were treated on the Lokomat for a total of 24 sessions. The goal was to 
train patients twice a week, for 12 weeks. However, due to logistics-related problems 
or health-related complications, we were not able to train all patients twice a week. 
Nevertheless, we made sure that the 24 session were performed within 4 months. 
When needed, patients incidentally received 3 therapy sessions a week to meet this 
goal. All outcome measures were assessed before and after the intervention.
Intervention
The device used for robot-assisted treadmill training was the Lokomat. The 
design and control of the Lokomat has been reported previously.2 In this study, 
the LokomatPro device (Hocoma, Switzerland) was used with the Levi bodyweight 
support system. Three settings were manipulated during this study: speed, amount 
of body weight support (BWS) and the amount of assistance of the robotic orthoses, 
Guidance Force (GF). Patients were instructed to actively follow the walking pattern 
of the device. The ultimate goal was to walk at high but still comfortable speed, with 
as little BWS and GF as possible for as many minutes possible within the therapy 
time. No attempt was made to monitor the forces of the interaction between the 
participant and the device. We used settings the patients were still able to walk with 
for about 20-45 minutes without fatiguing. The duration of the training sessions was 
60 minutes, including preparation time. Lokomat therapy was part of the normal 
rehabilitation program. Patients were allowed to perform other gait related therapies 
or activities when possible. We allowed the additional practice of walking overground 
to allow the transfer of skills from the treadmill environment to ADL-activities.1,7,15-17
Outcome measures
Before start of the intervention, demographic data were collected and ASIA 
classification was assessed (including upper- and lower-extremity motor scores, 
UEMS and LEMS, respectively). Primary outcome measure was walking speed at 
the timed 10m walk test. When patients were not capable of walking over the full 
10-m walkway, walking speed was set to zero for the data analysis. We characterized 
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baseline stepping ability before start of the intervention by assessing whether 
patients were able to make at least one step, when necessary with a walker or side 
bars, but without long leg splints. Secondary outcome measures were Functional 
Ambulation Categories (FAC),18 Berg Balance Scale (BBS),19 Rivermead Mobility Index 
(RMI),20 Hoffer classification (HOF),21 self-selected Walking Index for Spinal Cord 
Injury II (WISCI II),18 and Timed get-up and go test (TUG).22 
Data Analysis
To compare the difference between outcome measures before and after training, 
we analyzed both the non-parametric and the parametric outcome measures using 
a Wilcoxon signed rank test, because of the small sample size and the non-normality 
of the data. A p<.05 was considered statistically significant. Effect size was calculated 
using r.23 All analyses were performed using PASW version 18.0. Spearman correlation 
was used to study the relationship between LEMS and initial- and change in walking 
speed. Parametric data are reported as means with standard deviation. Non-
parametric data are reported as median and interquartile range (IQR).
RESULTS
We recruited 21 subjects to participate in the study. Of these 21 patients, three 
subjects were not able to complete the 24 training sessions within four months. One 
subject had an injury not related to the intervention. For two other patients, Lokomat 
therapy was discontinued because they had severe unilateral knee-extensor spasm 
while walking in the Lokomat. Demographic data of the 18 patients who completed 
the 24 therapy sessions are presented in Table 1. There was great variation among 
patients before start of the intervention in lesion level, time after SCI and functional 
ability. Three patients were classified as ASIA B, 8 patients as ASIA C and 7 patients 
as ASIA D (Table 1). 
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Table 1: Patient characteristics at start of the study
Patient Sex Age 
(yrs.)
Time after SCI 
(yrs.)
ASIA classification and 
lesion level 
LEMS pre UEMS pre
1 M 21 0.4 B (L3) 16 50
2 F 66 5.7 D (C1) 41 50
3 M 23 0.4 D (C6) 39 41
4 M 63 0.4 D (C5) 50 34
5 F 33 0.2 C (C5) 13 38
6 F 58 17.3 C (Th4) 10 50
7 M 35 0.9 C (Th5) 19 50
8 F 34 7.7 D (Th7) 31 50
9 F 31 11.5 C (Th9) 25 50
10 M 55 2.2 C (Th4) 6 50
11 M 57 0.6 B (C4) 0 0
12 F 40 0.6 C (C6) 15 23
13 M 51 9.0 C (L1) 11 50
14 F 43 34.5 C (Th8) 12 50
15 M 55 2.5 B (Th7) 0 50
16 M 63 5.1 D (C3) 44 20
17 M 66 6.0 D (Th10) 26 50
18 M 62 1.2 D (Th10) 40 50
Group 
descriptives
48 (15)* 2.4 (7.4)# 18 (29)# 50 (13)#
LEMS=Lower extremity motor score according to ASIA. UEMS=Upper extremity motor score according 
to ASIA. * Mean (SD), # Median (IQR)
Changes in outcome measures
The primary outcome measure walking speed was significantly higher after 
(median 0.15 m/s, IQR=0.60) than before the intervention (median 0.09 m/s ,IQR=0.37), 
z=-2.621, p<0.009, r=0.44 average improvement in walking speed was 0.08 m/s. Figure 
1 shows the individual values for walking speed before and after intervention, with the 
dotted line indicating the minimal detectable change in walking speed (>0.05 m/s,7). 
This minimal detectable change of walking speed is the size of the change required 
to exceed measurement error.24 Nine patients improved their walking speed beyond 
this minimal detectable change. Furthermore, 5 patients did not regain 10 meter 
walking ability after the intervention (Table 2). Initial walking speed was related to 
LEMS (r=.68, p=.002), whereas change in walking speed was not (r=.16, p=.53).
Individual data of the secondary outcome measures on function are shown in 
Robot-assisted w
alking after spinal cord injury
111
Table 2. Four patients who were able to make at least one step were not able to cover 
the full 10 meters of the walkway before the intervention. One of these patients (nr 
14) was not able to perform the 10m walk test on both occasions because of pain in 
the ankle joint; (Table 2). When we performed the analysis again with the patients 
with an ability to make at least one step having the same walking speed before and 
after the intervention, there was still a significant (p=0.047) improvement during the 
intervention period in walking speed. 
The median changes in outcome and results of the statistical analyses of RMI, 
BBS, FAC, WISCI II and Hoffer classification are presented in Table 3. Besides the 
improvement in walking speed, there was a significant improvement in the RMI (5 
patients improved). Furthermore, there was a trend in the improvement of the Berg 
Balance Scale (4 patients improved). The Functional Ambulation Category, WISCI II 
score and the Hoffer classification did not change significantly (3 patients improved in 
FAC and WISCI II scores and 2 in the Hoffer classification). The TUG test could only be 
performed by 6 patients at start of the study and by 9 patients after the intervention. 
Patient 1 did not perform TUG after the intervention because of fatigue. We used ‘last 
one carried forward imputation’ for the analysis. The analysis of the six patients with 
2 measurements for TUG revealed a trend (p=0.08) (5 patients improved their TUG). 
Figure 1: Individual results of walking speed measured before the intervention and after 
the intervention. The line of identity (x=y, dashed) and the line indicating clinically relevant 
improvement (x=y+0.05, dotted) is also depicted in the figure, along with labels of the 
individual patients.
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Table 3: Changes in clinical test scores and corresponding P-values (Wilcoxon signed rank test)
At start of 
intervention
median (IQR)
After 
intervention
median (IQR)
p-value Change Effect size 
(r)
Median 
(IQR)
Average 
(SD)
RMI (0-14) 6 (3) 7 (4) 0.04 0 (1.3) +0.8 (1.5) 0.34
BBS (0-56) 14 (9) 13 (13) 0.07 0 (0) +0.8 (2.0) 0.30
FAC (0-5) 3 (4.0) 4 (4) 0.10 0 (0)    +0.2 (0.6) 0.27
WISCI II (0-20) 9 (8) 9 (7) 0.11 0 (0)   +1.2 (3.4) 0.27
Hoffer(1-4) 2 (1) 2 (2) 0.16 0 (0)    +0.1 (0.3) 0.24
DISCUSSION
This pilot study showed that during an intervention of 24 sessions of Lokomat 
therapy combined with overground therapy walking ability can improve in patients 
with incomplete SCI. The primary outcome measure walking speed was not only 
significantly higher after intervention, average gain in walking speed exceeded 
measurement error (>.05m/s 7) and effect size was medium to large.23 Furthermore, 
patients’ bed mobility, postural transfers, and walking ability, as measured with the 
Rivermead Mobility Index, also improved significantly. Moreover, we found a trend 
for improved balance and there was an indication that performance of the timed-
up and go test also improved. However, of the 9 patients who improved in walking 
speed beyond the minimal detectable change of 0.05 m/s,7 it appears that 5 out of 
these 9 patients were within 1 year after onset of SCI. From literature, we know that 
spontaneous recovery is common in the first year after SCI.25 It is therefore possible 
that the improvements of these patients are (at least partially) due to spontaneous 
recovery rather than to a therapy effect. On the other hand, the other 4 patients who 
improved in walking speed had a chronic lesion; for these patients we can assume 
that the improvements seen in these patients are due to therapy. Outcome measures 
focused on ambulatory status (Hoffer classification), independency of walking (FAC 
score), and amount of physical assistance, braces or devices (WISCI score) did not 
change significantly. Noteworthy is that, for the chronic group of patients, individual 
scores of WISCI, FAC, Hoffer and BBS tests did not change in our sample of patients. 
These results indicate that, for most patients, gains in walking ability were small. We, 
therefore, suggest that our intervention with moderate frequency may be effective 
for some patients, while it seems not effective for a number of patients.
In literature, lower extremity motor score (LEMS) has been assigned a role in 
explaining improvements in walking ability. The rate of recovery of LEMS is rapid 
during the first three months and the improvement plateaus between 9 months 
Chapter 7
114
up to 18 months.25 LEMS measured shortly after SCI has been shown to predict the 
likelihood of independent walking one year after SCI.26 In line with other studies, 
at baseline, we found that LEMS was significantly related to walking speed. In 
cross-sectional studies, a relation between LEMS and walking speed has been 
demonstrated for a group of patients with recent injury27 and a group of ambulatory 
patients with chronic lesions.28 However, in our study, change in walking speed was 
not related to initial LEMS, which is in line with a study in chronic patients, showing, 
that improvements in walking speed were not correlated with improvements in 
LEMS.4 We did not measure LEMS after the intervention, so we cannot investigate 
whether changes in LEMS were related to changes in walking ability in this study.
Larger gains in outcome measures have been reported than in our present study, 
which might be due to differences in number of training sessions in the interventions 
studied. Most studies report effects of interventions that employed Lokomat 
therapy (or BWSTT) more than 2 sessions per week, even up to 5 times per week. 
The literature on the effectiveness of the Lokomat4-8 is in line with the literature on 
studies on the effectiveness of BWSTT: in quasi experimental trials claimed positive 
effect for BWSTT,1,29 while in an RCT (50+ patients per group) on the effectiveness of 
BWSTT27,30 it was demonstrated that differences in improvement between BWSTT and 
overground therapy were not significant. Thus, currently there is no firm evidence 
suggesting that one therapy is more beneficial than others in improving walking 
ability after iSCI. Reviews stress the necessity of large scale RCTs to investigate the 
recovery of walking ability.16,17,31
Despite the minor changes in walking ability, there may be other rationales to 
prescribe Lokomat therapy for individuals with iSCI. Small gains in walking ability can 
make a difference for patient’s lives.1 It has been suggested that, even for patients 
who do not considerably improve walking ability, treadmill training may have benefits 
other than solely in the functional realm.32 It is argued that BWSTT, and presumably 
robot-assisted therapy as well, have benefits associated with verticalization of the 
body, especially in wheelchair-dependent patients. In a randomized clinical study with 
non-ambulatory stroke subjects, for example, it was demonstrated that Lokomat 
therapy has the potential to improve body composition,33 potentially decreasing 
cardiovascular risk factors. Furthermore, there are studies suggesting a potential for 
BWSTT to improve psychological well-being.32 During interviews with the participants 
after the intervention in our study, subjects often indicated they had experienced 
beneficial effects not grasped by any of the measurement instruments used. Among 
those statements were ‘My legs feel warm for more than a day after walking in the 
Lokomat, that’s a pleasant feeling’ (ASIA B), ‘Now I can stand up straight, which 
makes dressing myself much easier’ (ASIA C). ‘Before the intervention I suffered 
from cystitis every 2 months. During the intervention period however, I have not had 
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urinary tract infection’ (ASIA C) and ‘I can defecate more easily (ASIA A, B). Although 
these statements are anecdotal, we believe they may provide indications for 
directions for future studies. Therefore, other secondary measurements should be 
performed to investigate the beneficial effects on other spectra of improvements of 
daily life than solely on the effectiveness of BWSTT or Lokomat therapy in improving 
walking ability. 
To conclude, during our intervention with Lokomat therapy with additional 
overground walking, patients improve some aspects of walking ability. However, 
it is also important to note that a number of patients did not improve during the 
intervention which may have led, to unrealistic group results. This study does not 
confirm nor disprove the superiority of more loosely constraint limb trajectories as 
found in animal models. Future research should point out whether the Lokomat can 
perhaps be used more effectively, using different device settings, other volume or 
frequency of therapy, or in combination with other therapies. Before large scale 
multi centre trials are performed it is necessary to first identify the optimal use of the 
Lokomat, only then should larger efficacy trials be performed. Finally, since the costs 
of healthcare are rising, future studies should incorporate cost-effectiveness of this 
robot-assisted walking therapy.
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The goal of this thesis was to evaluate the use of the Lokomat in rehabilitation 
practice after stroke and spinal cord injury. We studied the effectiveness of the device 
in improving walking ability, assessed the effects of walking in the device on the 
cardiorespiratory system, examined the muscle activity during walking in the device 
and studied the association between recovery of balance and recovery of strength 
of the paretic knee extensors. The first subsection of the discussion summarizes 
the main findings of this thesis and discusses a selection of methodological 
considerations in relation to the study design, selection of study populations and 
outcome measures. In the second subsection of this chapter, implications of present 
insights and recommendations for future research are discussed.
MAJOR FINDINGS AND METHODOLOGICAL CONSIDERATIONS
First, we’ll discuss the choices we made for how we used the Lokomat and the 
frequency of the intervention. Next, the study on the evaluations of muscle activation 
during walking in the Lokomat will be discussed, whereupon the experiments on 
the evaluation of the effects of the Lokomat on the cardiorespiratory system are 
reviewed. Third, the effectiveness of improving walking ability using our intervention 
with the Lokomat are discussed. Finally, the evaluation of the relationship between 
balance and strength deficit after stroke is examined.
Considerations on the intervention and use of the device
Obviously, the Lokomat device can be employed in various ways, frequencies and 
durations. In the present thesis, the adjustments of the settings of the device were 
based on the clinical recommendations of the developer of the device (Hocoma, 
Switzerland), which in practice comes down to gradually decreasing the assistance of 
the device as much as possible.  These recommendations are based on the opinion of 
a panel of expert researchers cooperating with the developer. In this thesis, the term 
‘optimal settings’ refers to the settings with the assistance of the device decreased 
as much as possible while still allowing comfortable walking for the patients for a 
continuous bout of exercise. 
The frequency and duration of the intervention was based on considerations 
of practical and financial feasibility. The Dutch reimbursement system and the 
organization in the rehabilitation centre allowed a certain amount of therapy per 
patient with stroke which limited the number of therapy sessions per week in the 
Lokomat to 2 sessions of one hour. Besides similar considerations for the choice of 
the frequency for the intervention of individuals with spinal cord injury, an additional 
feature of the intervention was that we did not want to intervene too much in the 
lives of the patients who had regular daytime jobs. All together, therefore, we think 
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that the frequency of the intervention is realistic in terms of what is presently possible 
within the present constraints of the daily life of patients and our health care system.
Muscle activity during walking in the Lokomat
Although walking in the Lokomat may be comfortable and may seem to 
generate near to normal kinematics of walking in even the most impaired patient, 
it is important to evaluate the (voluntary) activity during walking in the device to 
better understand possible mechanisms of therapy.1 In chapter 2 we approached 
this by measuring muscle activity of several lower-limb muscles of individuals with 
stroke during walking both in the Lokomat device and during overground walking. 
The objective of this study was to compare walking in the Lokomat with minimal 
assistance as provided during regular therapy with walking overground. Detailed 
analyses of muscle activity revealed several differences during the gait cycle in 
the activity in various muscles. Apparently, muscle activity patterns (qualitatively) 
changed compared to the naturally occurring muscle activation patterns during 
overground walking. In order to produce a general statement on the effects of the 
support and restrictions of the device on muscle activity, we broke the stride up into 
two phases, stance phase and swing phase. The general picture is that during walking 
in the Lokomat, on average, the EMG amplitudes were equal or lower (although not 
always significantly) than during overground walking during both stance and swing 
phase. The significantly lower EMG amplitudes of the gastrocnemius muscle and 
the gluteus medius during stance phase of walking in the Lokomat may be caused 
by the assistance of the body weight support or the reduced degrees of freedom. 
The assistance of the orthoses during swing may have caused the decreased activity 
in the semitendinosus and tibialis anterior muscles. Although the activity of some 
muscles may be different during walking in the Lokomat compared to overground 
walking, this does not mean that it is not a suitable therapy to practice walking. 
Indeed, in severely affected neurological patients, degrees of freedom need to be 
reduced to make walking possible. Additionally, lower EMG suggests lower efforts of 
the muscles, which may allow patients to practice walking for longer duration.
A limitation of this study (chapter 2) may be the choice for the patients who 
were elected to participate in the experiment. The ability to walk independently was 
deemed important to be able to compare muscle activity patterns during overground 
walking with that during walking in the Lokomat. The participating patients had the 
same diagnosis as those recruited for the trial (chapter 4), but they had a much 
better walking ability. Another limitation may have been the limited experience the 
patients had with walking in the device. This appears to have led to sub-optimal 
settings (relatively high assistance) because, typically, more impaired patients 
enrolled in the trial (chapter 4) could already walk at more advanced settings after 
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a few training sessions. Together, therefore, the differences between robot-assisted 
walking and overground walking we observed in this study may not be indicative 
for more impaired individuals with experience in walking on the device and results 
should therefore be interpreted with caution. Furthermore, another limitation which 
should be controlled in future studies is the speed during Lokomat and overground 
walking. Speed has been demonstrated to affect muscle activity patterns during 
overground walking2 and should therefore, preferably be similar during different 
modes of walking. However, in this regard, it is relevant to note that during walking 
in the Lokomat, horizontal propulsion of the centre of mass does not need to be 
generated by leg muscles, as the position of the pelvis and upper body is held over 
the same position of the treadmill by the device. This assistance of the Lokomat in the 
horizontal propulsion might affect the dependency of muscle activity during walking 
on speed. An indication that this may indeed occur is the finding of Hidler et al.3 that 
EMG activity during walking in the Lokomat in healthy subjects did not change with 
different speeds. Nevertheless, it is possible that results of a similar future study will 
be different to ours if speed is controlled properly.
To answer more specific questions (such as temporal aspects of muscle patterns) 
of the effects of the restrictions and assistance of the device, more sophisticated 
statistical techniques are required (cross-correlations4,5 or otherwise1). Future studies 
might address some of the concerns of physicians such as whether “patients can 
keep up with the speed of the device”, or about the muscle activity of patients with 
ASIA B, or whether the paradigm of “forced use” can be applied during walking in 
the Lokomat. Finally, a systematic study of the effects of various combinations of 
assistance of the device at various speeds may be useful to determine optimal use 
of the device.
The effect of Lokomat training on the cardiorespiratory system 
In chapter 3, we evaluated walking in the Lokomat in terms of the exercise 
intensity during walking in the device compared to walking overground. We were 
interested to learn what influence the restrictions and the assistance of the device 
had on the exercise intensity of patients. The results showed that exercise intensity 
levels during walking in the Lokomat in the group of stroke patients participating in 
this experiment were lower than during overground walking and ‘light’ according 
to general exercise recommendations. Based on these recommendations, Lokomat 
therapy would probably not lead to substantial improvements in cardiorespiratory 
fitness in stroke patients. Furthermore, in healthy subjects it was demonstrated 
that more challenging settings did not lead to higher cardiorespiratory intensities 
of walking. Therefore, we concluded that it is unlikely that substantial exercise 
intensity can be achieved in the Lokomat with the combination of settings used in 
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this experiment. 
A limitation of this study (chaper 3) may be the use of healthy individuals as model 
for patients. It has been demonstrated that there are essential differences in exercise 
intensity during walking between hemiparetic stroke patients and healthy subjects.6,7 
Nevertheless, the most interesting part in the analysis of difference between patients 
and healthy subjects during different modes of walking is the observation of an 
interaction between mode of walking and subject group. It shows that patients 
respond differently to the assistance of the device than non-disabled subjects. 
Moreover, we did not find a significant difference between the exercise intensity 
during Lokomat walking in patients and healthy subjects, which may suggest that 
healthy subjects can be accepted as a model for patients for the purpose of this 
study. However, these analyses are limited by the heterogeneity of the patients 
in terms of walking ability and the differences in settings which were used during 
Lokomat walking among patients and between the group of patients and the group 
of healthy subjects. Therefore, because we cannot be sure whether healthy subjects 
are indeed valid models for patients we need to cautiously interpret the results that 
settings of the device did not affect exercise intensity found in healthy subjects. 
Moreover, whether our conclusion holds for other combinations of settings remains 
to be established. 
In chapter 6 we studied the exercise intensity of walking in the Lokomat in patients 
with incomplete spinal cord injury. Similar to stroke patients, exercise intensity in this 
group of patients with spinal cord injury was ‘light’ compared to general exercise 
recommendations. Because Lokomat therapy may provide an alternative exercise 
modality for functional electrical stimulation-induced exercise in patients with a still 
intact sensory system, and for arm crank or wheelchair exercise for patients who may 
be prone to shoulder overuse, we studied the effects of a 24-session intervention 
with Lokomat training on cardiorespiratory fitness. As we were interested in 
improvements of cardiorespiratory fitness related to central adaptations rather 
than peripheral changes we performed an arm crank exercise test. We assumed that 
voluntary activation of the arms did not change during the course of the intervention. 
Although this may have been questionable for the two subacute patients (chapter 
6, Table 1, Figure 2 C5, D2), inspection of the data showed that these patients did 
not improve in peak heart rate and peak oxygen consumption, indicating that it is 
unlikely that they employed more muscle mass during the pre-test. The results of 
the cardiorespiratory fitness test suggested that, despite the low exercise intensity, 
an improvement in cardiorespiratory fitness was realized. However, although the 
heart rate during rest and submaximal exercise decreased on average by 7 beats per 
minute, we did not find a significant increase in oxygen pulse. We therefore concluded 
that likely improvements were small. 
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This study is limited by not having a control group in the design. Whether there 
is a causal relationship between the intervention of Lokomat therapy with additional 
therapy can only be established in a controlled trial with a group of patients receiving 
similar amount of conventional therapy. Moreover, it should be noted that as patients 
also received additional therapy, the improvements of the cardiorespiratory fitness 
cannot be causally related to the therapy with the Lokomat alone. Therefore, our 
results should be interpreted with caution.
Recovery of walking ability using a robotic device after stroke
For people with stroke, we studied the effectiveness of improving walking ability 
using the Lokomat in a randomized clinical trial with 30 patients. Chapter 4 showed 
that the intervention we used in our study did not improve outcome after stroke 
significantly more than conventional overground physical therapy. Moreover, at 
follow-up measurements, there were no significant differences in improvements 
between groups in any of the outcome measures. Therefore, we concluded that the 
intervention we used in our study (8 weeks, 2 sessions/wk) was equally effective in 
improving walking ability as conventional therapy after stroke. We recommend that, 
for now, whether or not the present intervention with the Lokomat should be used 
in clinical practice should predominantly be based on cost-effectiveness or practical 
considerations for example on the number of available therapists to treat a patient 
with severely affected gait. 
One of the qualities of this study is that it investigated an intervention that 
fitted both practically and financially in the organization of the rehabilitation centre 
and was only experimental in the sense of the content of the therapy, not in the 
amount of contact with physical therapists. Another quality of the study design is the 
relatively long follow-up period. Assessments at wk 24 and wk 36 after start of the 
study are rarely performed in the literature on the effectiveness of the Lokomat, but 
are essential to assess whether superiority of a therapy is permanent. Using such a 
design decreases the chance of a premature conclusion. 
Limitations of the study were the different moments after stroke at which 
patients entered the study and the heterogeneity of impairment level of the patient 
group in combination with small sample size. This might raise concerns about the 
power of the analyses. However, the differences in improvements between control 
and intervention over the intervention period had low effect size for all outcome 
measures. Moreover, power analyses based on the available data revealed that 160 
patients needed to be recruited to be able to demonstrate a significant improvement. 
As the effect size of such an analysis is small, the clinical relevance of such a result 
would be questionable.
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Recovery of walking ability using a robotic device after spinal cord injury
Chapter 7 addressed the question of effectiveness of Lokomat therapy on 
improvements in walking ability and related outcomes after spinal cord injury. After 
the intervention period, patients significantly improvements in walking speed and 
Rivermead Mobility Index, indicating improved walking ability. Although results were 
significant at group level, it should be noted that there was quite some variation in 
the size of improvement among subjects. We used the minimal detectable difference 
for change in walking speed (0.05 m/s) to identify a ‘true’ improvement.8 Researchers 
and clinicians can use this value to determine whether there is a true difference in 
performance or whether the difference between two tests is within measurement 
variability.8 Results showed that 9 out of 18 patients improved beyond measurement 
variability. Moreover, to improve in outcome measures such as the Hoffer 
classification, the Functional Ambulation Categories and Walking index for Spinal 
Cord Injury, patients need to substantially improve in performance. The absence of 
significant improvements in these measures indicates that changes in walking ability 
are small. However, in line with Hicks et al.9 we observed that Lokomat therapy might 
have value beyond the potential to improve walking ability. Through unstructured 
interviews, feedback was acquired on effects not measured by any of the outcome 
measures but which were beneficial for the patients (such as disappearance of urinary 
tract infections). Although these effects are anecdotal and not structurally studied, 
they may provide leads for new outcome measures for future research. 
Because of the low prevalence of patients with incomplete spinal cord injury 
who were able to participate in a study in combination with the heterogeneity of 
the sample, we adopted a pre-experimental design without a control group. An 
alternative design might have been a cross-over design. However, if the condition 
under study can change rapidly regardless of the intervention, the use of this design 
is controversial.10 Possibly, the strength of the evidence of this study could have been 
improved by performing multiple baseline measurements, that way, improvements 
due to ‘latent capacity’ could have been excluded.11 The downside of more baseline 
measurements is that it conflicts with our goal of providing therapy as soon as 
possible.12 The consequences of the use of our design is that it does not allow us 
to infer that the changes in walking ability were caused by our intervention or the 
Lokomat in particular, and results should therefore be interpreted with caution.11
Associations between strength of the paretic knee extensors and balance after 
stroke
In chapter 5 we demonstrated that absolute values of balance (measured with Berg 
Balance Scale) and isometric strength of the paretic knee extensors are interrelated 
at multiple assessments after stroke. Moreover, the regression coefficient seemed 
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to be higher as recovery progressed. This is possibly due to the combination of two 
findings in the literature on recovery after stroke: the relationship between initial 
impairments and reductions in impairment and compensation strategies that allow 
patients to improve (on average) relatively more in performance of functional 
activities than in impairment. Furthermore, we demonstrated a significant relationship 
between the change in balance and the change in strength of the paretic knee 
extensors over the interval of wk1-wk10 of the study, indicating that improvements in 
strength are associated with changes in balance. However, over the interval of wk10-
wk24, there was no significant relationship between the change in isometric strength 
and changes in balance. These results indicate that differential mechanisms may be 
responsible for the recovery of these two variables. Strength can increase through 
improved voluntary activation or through increased cross-sectional area of the 
muscle. Possibly, during the interval of wk1-wk10, the improvements in strength were 
mostly due to improvements in voluntary activation, whereas during the interval of 
wk10-wk24, the improvements in strength were related to improvements in cross-
sectional area of the knee extensors.13 It is conceivable that improvements in strength 
due to improved voluntary activation are differently associated with improvements 
of balance compared to improvements in strength due to increased cross-sectional 
area. Alternatively, it is possible that inter-individual differences in improvements of 
balance, possibly through learning different compensatory strategies to maintain 
balance, have led to the non-significant relationship. Finally, other mechanisms, 
important for maintaining balance such as improved sensory integration or improved 
motor function in other muscles may have led to more variability in improvements in 
balance. 
There are some methodological considerations of our study that need to be 
discussed. As a measure for balance we used the Berg Balance Score, which is 
suggested to be a measure of ‘standing balance’14 and which is often used in research 
and clinical practice and has good reproducibility.15 Obviously, there are more 
ways to measure the concept of ‘balance’,16 which might possibly lead to different 
insights. The measure we used for strength of the paretic leg (voluntary strength of 
the knee extensors) has some limitations. First, other muscles might be differently 
affected.17 Second, in this study we could not differentiate between hypertrophy and 
improvements in voluntary activation. Third, the non-paretic voluntary activation 
is also affected after stroke, which we did not take into account.17 Fourth, the 
relationships may be different when strength is measured at different knee angles 
and other joints.18 Finally, isometric strength is not the same as dynamic strength or 
strength during synergistic movements.19 These limitations should be kept in mind 
when interpreting the results.
Future studies may focus on the associations between the improvements 
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in performance of functional activities and improvements of variables at the 
impairment level, such as sensory function, and motor function of several muscles 
which should not be limited to the paretic side of the body. Such analyses are useful 
in understanding the relationship between changes in impairments and performance 
of functional activities. However, whether the associations found in our study 
change with statistical significance needs to confirmed using longitudinal statistics. 
In future studies, Generalized Estimating Equations or Random Coefficient Analyses 
can be used to test whether associations are significantly different. As we had only 
23 subjects available for the analyses, we did not perform such an analysis as the 
analyses would be underpowered.
PRESENT INSIGHTS AND FUTURE STUDIES
Cochrane reviews and other systematic studies on effectiveness of therapy 
focused on improving walking ability after stroke conclude that there does not seem 
to be a clearly superior therapy available and that there is insufficient evidence to 
base firm conclusions on whether a certain therapy is superior in the long run.20-24 
Although two studies on the effectiveness of the Lokomat showed differentiating 
effects in improvements of walking ability with sub-acute stroke patients,25,26 other 
studies did not find evidence for a superiority of any therapy.27-29 Our results (chapter 
4) add to the evidence suggesting that there is no difference between effectiveness 
of Lokomat therapy and conventional therapy on improving walking ability after 
stroke.
The literature on research on the effectiveness of therapy to improve walking 
ability after SCI is less abundant than for stroke. Presently there is debate on 
whether bodyweight supported treadmill training or Lokomat therapy should be 
used in rehabilitation after incomplete SCI.30-33 The few RCTs performed suggest 
similar effectiveness compared to overground therapy.34-38 Moreover, other studies, 
including systematic reviews, suggest that patients improve, regardless of therapy 
and that there is no evidence suggesting that any therapy is superior to another.39-41 
Unfortunately, our results (chapter 7) do not add strong evidence for effectiveness 
of Lokomat therapy, as we do not know whether improvements could have been 
realized with other therapies.
Taking the entire literature on functional recovery into account, some authors 
question whether therapy in rehabilitation practice is presently optimal and whether 
we are making any relevant contribution to recovery whatsoever.42 In the following 
part of the discussion, implications of the present insights in neurorehabilitation 
and recommendations for future research are discussed. First, evidence for the 
potential for functional recovery in animals and humans is discussed. Second, future 
developments are touched upon and future research is suggested.
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Functional recovery
Studies both on animals and humans suggest that functional recovery after 
neurological injury goes hand in hand with plastic changes in the structure of the brain 
(after stroke) or in the spinal cord (after SCI). Plasticity is broadly defined as the ability 
of the nervous system to respond to intrinsic and extrinsic stimuli by reorganizing its 
structure, function and connections.43 These changes in the central nervous system 
and concomitant functional improvements  seem partly spontaneous (meaning not 
under our control or influence) and partly treatment induced.44 The spontaneous 
recovery after stroke is associated with recovery of functionally inactive but viable 
tissue in the brain.45 Treatment induced plasticity after lesions to the brain has been 
demonstrated in several studies by structural changes in the brain which could be 
explained by practice of the involved limb.44,46 Early practice after brain lesion has 
effects on the size of projection areas of the brain after injury.47,48 After spinal cord 
injury, spontaneous recovery is associated with sprouting or reorganization in the 
spinal cord unrelated to treatment.49 Moreover, in SCI, there are indications that 
practice elicits changes at the spinal level.50 Therefore, early rehabilitation practice is 
focused on bringing about changes in neural structure.42,50
Although animal studies have shown encouraging results, we need to be aware of 
essential differences in the recovery after brain injury between animals and humans 
and differences between study procedures. There seem to be crucial differences in the 
anatomy, and type of lesion between animal models for stroke and spinal cord injury 
and humans with stroke or spinal cord injury.51 Furthermore, current intervention 
studies or therapies do not have similar doses of practice as animal studies nor similar 
levels of enrichment of the environment.52,53 Nevertheless, these animal studies can 
provide a direction for studies in humans.
In humans, after stroke or SCI, it is presently not clear how much of the recovery is 
spontaneous and how much is treatment induced.54 Indeed, for now, the equivalence 
of therapies may suggest that spontaneous recovery may be responsible for the 
larger part of improvements rather than any practice. Alternatively, it could suggest 
that both control and other interventions are (near) optimal therapies. The promising 
results of functional improvements by practice achieved in animal models, have not 
been replicated in humans.42 According to theory, treatment induced improvements 
can be obtained through learning mechanisms.55 Research on motor learning has 
produced several insights on how skills are acquired and which factors may lead to 
optimal learning.56 The standard ingredients of motor learning are high-intensity, 
repetitive and task-specific practice. Furthermore, feedback on performance, goal 
setting, context specificity of therapy, patient motivation or engagement and specific 
instructions are related to more improvement.56 Recently, in addition to these 
factors, the role of variability has been suggested as an additional rule in ‘differential 
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learning’.56,57 Some of these ingredients, intensity of practice and task specificity of 
practice, have already been demonstrated to result in enhanced functional recovery 
after stroke.58,59
Thus, through motor learning patients may be able to improve in function. 
Improvements in function are realized through the recovery mechanisms ‘restitution’ 
and ‘compensation’.60 Restitution leads to a return of the pre lesion movement, 
function, or tissue, whereas compensation is associated with emergence of new 
movement strategies that differ from the original, other functionality of neural tissue 
or compensatory use of other limbs.60 Presently, there is still a lack of understanding of 
how much of functional recovery is achieved through restitution or compensation.45 
Efforts are made to come up with tests to elucidate the relative contribution to 
functional improvement.61,62 Such information is valuable for clinical practice because 
it may help to optimize recovery. 
In conclusion, animal studies and studies on changes in the central nervous system 
suggest that there may be some windows of opportunity to improve functional 
ability.42 One major objective lying ahead of us is to identify an effective application of 
motor learning theory in an optimal intervention and to improve our understanding 
of why such an intervention is succesful.55,56 For now, however, we can conclude that 
there is still a gap between what we think the potential for recovery is after stroke 
and spinal cord injury and what we have accomplished so far by interventions.
Future prospects for Lokomat and other robot-assisted  therapies
Manufacturers of rehabilitation equipment have developed and continued to 
redesign products that may be used in research laboratories and in clinical practice. 
Besides the Lokomat, examples of such devices are the Lopes63 or the Gait Trainer.64 
In the current healthcare market, these innovative devices create a demand for 
themselves in local rehabilitation centers and clinical administrators are purchasing 
such devices, and clinicians are implementing their use in rehabilitation practice 
before efficacy has been demonstrated. Because these innovations are becoming 
available on the market before efficacy has been properly demonstrated we need 
to treat such therapies as experimental therapies and may need to be cautious with 
implementing them in practice. Nevertheless, innovation in neurorehabilitation is 
needed and should be encouraged as current therapy outcome is not satisfactory. 
Moreover, these developments create chances for researchers as more funding may 
become available for these innovative therapies. The development of new therapies 
needs to go through a progressive staging of rigorous testing. The first step is to 
study how to optimally employ the devices in terms of adjusting settings such as 
speed, amount of body weight support, duration, intensity of training exercise.11 
Moreover, subgroups of patients for who this therapy is effective need to be 
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identified. Collaboration among several rehabilitation institutes is essential to gather 
such devices, particularly in a small country as the Netherlands. 
We recommend that future studies on the effectiveness of therapy should include 
long term follow up assessments. There is convincing evidence that patients are 
capable of improving their performance of functional activities up to at least 1 year 
post stroke65 and after SCI.49 The importance of a follow-up measurement became 
particularly evident in a high quality trial (>400 participants) by Duncan et al.66 which 
included follow-up assessments at 1 year after stroke. It was demonstrated that at 
6 months there seemed to be a superior effect for one of the intervention groups. 
However, 1 year after stroke, all patients had improved relative to 6 months before 
and the group differences had disappeared. Such a result stresses the importance of 
long term follow-up measurements, since otherwise this can lead to an erroneous 
premature conclusion. The collected efforts to investigate the effectiveness of such 
device should therefore definitely include such long term follow-up measurements.
Some authors have suggested that early practice may lead to superior outcome.67 
If this proves to be true this will have drastic consequences for the organization of 
rehabilitation in the institutes in the chain of care. Moreover, increasing the frequency 
of repetitions and the ‘volume’ of therapy42 will be an additional challenge when we 
want to apply it in the daily practice of rehabilitation of patients since there are many 
more problems that need attention during rehabilitation than only the rehabilitation 
of motor function. Nevertheless, robotic systems may have a role in these future 
developments because they have the potential to administer motor learning principles 
such as massed practice and (arguably) task specific and variable training especially 
for the severely impaired patients. Treadmill exercise, with or without a robotic 
device, that enables aerobic exercise could offer potential advantages for subgroups 
of more severely disabled persons. Moreover, further into the future, new treatments 
approaches will be tested and possibly implemented in routine rehabilitation such 
as brain stimulation in stroke (direct current stimulation68 or transcranial magnetic 
stimulation69) or administering pharmaceuticals (such as Fluoxetine70). Examples 
for new treatments in development for SCI are (epidural) electrical stimulation 
techniques and pharmaceutical substances.71,72 In the future, a combination of these 
treatments is possibly a sensible path to follow in neurorehabilitation. Meanwhile, we 
need to better understand recovery mechanisms and to try to apply this knowledge 
for optimization of therapy. One of the major challenges in neurorehabilitation 
research is to come up with a therapy and to indisputably demonstrate that we can 
permanently induce neurological and functional improvement in patients beyond the 
outcome of presently used therapies.
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The Lokomat is a device consisting of a treadmill, body weight support system 
and two robotic orthoses which can guide the legs of severely affected neurological 
patients during walking on the treadmill. The goal of this thesis was to evaluate the 
use of the Lokomat in rehabilitation after stroke and spinal cord injury. We studied the 
effectiveness of the Lokomat in improving walking ability (chapter 4 & 7), assessed 
the effects of walking in the Lokomat on the cardiorespiratory system (chapter 3 & 6), 
examined muscle activation patterns during walking in the Lokomat (chapter 2) and 
studied the association between recovery of strength of the paretic leg and balance 
(chapter 5). Chapters 2 to 5 were focused on stroke patients, whereas chapters 6 & 7 
were focused on patients with spinal cord injury.
To evaluate the influence of the assistance of the Lokomat and the limited 
degrees of freedom in terms of muscle activity we compared electromyography of 
leg muscles in stroke patients during walking in the Lokomat and during overground 
walking (chapter 2). Furthermore, a set of ‘normative’ muscle activity patterns 
was assessed in healthy subjects walking unassisted. Results showed that, in most 
muscles, activity was equal or lower than during overground walking. Furthermore, 
for some muscles, activity seemed less associated with a pattern of muscle activity 
corresponding to that of healthy individuals walking overground. We concluded that 
training in the Lokomat may elicit lower muscle activity and changes in the naturally 
occurring muscle activation patterns during walking in some muscles. These results 
may be explained by the body weight support, by the assistance provided by the 
orthoses and by the limitations in degrees of freedom of the Lokomat.
In chapter 3, we studied the influence of the assistance of the Lokomat and the 
limited degrees of freedom during walking in the Lokomat on the cardiorespiratory 
system by comparing heart rate (HR) and oxygen consumption (V̇O2) during walking 
in the Lokomat and during overground walking. We concluded that exercise intensity 
levels during walking in the Lokomat were ‘light’ according to general exercise 
recommendations and lower compared to overground walking in the group of stroke 
patients participating in this experiment. These results suggest that, using this type of 
therapy, patients will probably not substantially improve in cardiorespiratory fitness. 
Furthermore, we demonstrated that more challenging settings of the Lokomat 
did not lead to higher cardiorespiratory intensities during walking in the Lokomat 
in healthy subjects. These results may suggest that it is unlikely that patients with 
stroke achieve substantial exercise intensity during walking in the Lokomat with the 
combination of settings used in this experiment. 
In chapter 4, we studied the effectiveness of the Lokomat relative to conventional 
therapies in improving walking ability in non-ambulatory stroke subjects involved 
in inpatient rehabilitation. The patients in the intervention group received 8 weeks 
of Lokomat therapy twice a week, together with 3 times 30 minutes a week of 
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conventional overground therapy. A control group received conventional assisted 
overground therapy during a similar amount of time. Outcome of therapy was 
assessed at study entry, after the intervention, and at wk24 and wk36 after baseline 
assessment. Patients showed significant improvements in walking speed, function and 
mobility, and strength of the paretic leg relative to baseline values at all assessments, 
but we found no significant differences between Lokomat and conventional training 
in improvements in any of the variables at any time during the study. Moreover, effect 
sizes of the differences in the improvements over the intervention period between 
groups were small in all outcome measures. We therefore concluded that Lokomat 
training is as effective as conventional training for increasing walking ability in non-
ambulatory stroke patients.
In chapter 5, we evaluated the association of balance and strength of the knee 
extensors at multiple assessments during the rehabilitation process after stroke. 
Balance and strength can both be clearly affected after stroke. In several cross-
sectional studies, performance of functional activities and measures of strength of 
the paretic leg have been shown to be related. However, during the rehabilitation 
process, both improve, and we have poor understanding of the course of the 
association of balance and strength of the knee extensors during the rehabilitation 
process. We demonstrated that there is a positive and significant relationship between 
these variables at all assessments. We observed that the association between balance 
and strength seems to improve over time, which is possibly due to the combination 
of two findings in the literature on recovery after stroke: the relationship between 
initial impairments and reductions in impairment and, secondly, the presence of 
compensation strategies that allow patients to improve (on average) relatively more 
in performance of functional activities than in impairment. Moreover, we found a 
significant association between changes in balance and changes in strength of the 
knee extensors over the period of wk1-wk10 of the study (relatively early after stroke), 
whereas there was no significant association over the period of wk10-wk24 of the 
study (relatively late after stroke). These findings may suggest that improvements of 
performance of functional activities are more related to improvements in voluntary 
activation than to improvements in cross-sectional area of the muscle. Alternatively, 
inter-individual differences in improvements in balance or improvements in other 
impairments which may affect balance (such as sensory function) may explain our 
results.
Interventions to promote physical activity in the spinal cord injury population 
are becoming increasingly important since being physically active may improve 
general health. In chapter 6, we studied the effect of a period of robot-assisted gait 
training on cardiorespiratory fitness. The training program consisted of a total of 24 
training sessions on the Lokomat with additional conventional therapy. To assess 
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the intensity of the training program, V̇O2 and HR were measured during training 
sessions. Cardiorespiratory fitness was assessed before and after the intervention in 
a graded arm crank exercise test. Results suggested that, participants exercised at 
’light’ intensity according to general exercise recommendations. Analyses of data of 
the exercise test however, showed that submaximal and resting HR was significantly 
lower after the intervention, with no significant changes in V̇O2 suggesting higher 
stroke volume. However, oxygen pulse did not significantly change. We concluded 
that in spite of the low exercise intensity of Lokomat therapy, this intervention may 
have a positive effect on cardiorespiratory fitness. However, likely improvements in 
cardiorespiratory fitness are small.
In chapter 7, we studied the effects of an intervention of 24 sessions of Lokomat 
therapy with additional overground walking over 4 months on ambulatory function, 
balance, participation and general health. Although at group level some results 
showed significant improvements between pre- and post test, there was quite some 
variation in the size of improvement among subjects. Moreover, the lack of an effect 
in all gait related outcome measured suggested that improvements were small. 
We concluded that during our intervention with Lokomat therapy with additional 
overground walking patients improve some aspects of walking ability, however, in 
most patients, gains in walking ability are small.
Finally, implications of present insights and recommendations for future research 
are discussed in chapter 8. Literature on animal studies and motor learning suggest 
that recovery of function after neurological injury is possible through practice. 
However, there is still a gap between the suggested potential for recovery after 
stroke and spinal cord injury and what we have accomplished so far by interventions. 
Research needs to focus on how to optimize therapy based on current knowledge. 
Moreover, it is essential to gain knowledge about how to optimally employ the 
Lokomat in terms of adjusting settings such as speed, amount of body weight support 
duration, amount and type of assistance of the orthoses and frequency of training 
before a final verdict can be made on the effectiveness of the Lokomat, or any such 
device. Research should also focus on identifying possible subgroups of patients who 
might benefit from this therapy. In order to succeed in this, particularly in a small 
country as the Netherlands, collaboration between several rehabilitation institutes 
in gathering such information is essential. Moreover, further into the future, new 
treatments will be developed, probably combining our present knowledge of motor 
learning with newly developed therapies (e.g. with brain or spinal cord  stimulation 
or pharmacological substances). In these future developments, robotic systems may 
have an important role. 
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De Lokomat is een apparaat dat bestaat uit een tredmolen, een harnas voor 
lichaamsgewichtondersteuning en twee robot armen die de benen van neurologische 
patiënten kunnen begeleiden tijdens het lopen op de tredmolen. Het doel van dit 
proefschrift was om het gebruik van de Lokomat tijdens de revalidatie na beroerte of 
dwarslaesie te evalueren. Daartoe is de effectiviteit van de Lokomat in het verbeteren 
van de loopvaardigheid bestudeerd (hoofdstuk 4 & 7), zijn de effecten op het 
cardiorespiratoire systeem tijdens het lopen in de Lokomat beoordeeld (hoofdstuk 
3 & 6), is de spieractiviteit onderzocht tijdens lopen in het de Lokomat (hoofdstuk 2) 
en is de relatie tussen herstel van kracht van de paretische kniestrekkers en balans na 
beroerte bekeken (hoofdstuk 5). Hoofdstuk 2 tot en met 5 richten zich op patiënten 
met beroerte en hoofdstuk 6 en 7 richten zich op patiënten met dwarslaesie.
Om de invloed van de assistentie van de Lokomat en de verminderde 
vrijheidsgraden te evalueren op de spieractiviteit (elektromyografie) van beenspieren 
van patiënten na een beroerte hebben we de spieractiviteit tijdens lopen in de 
Lokomat vergeleken met de spieractiviteit tijdens normaal lopen (hoofdstuk 2). 
Bovendien werd de spieractiviteit in een groep gezonde proefpersonen vastgelegd 
tijdens normaal lopen. De resultaten lieten zien dat de activiteit in de meeste spieren, 
lager of gelijk was tijdens lopen in de Lokomat vergeleken met normaal lopen. Voor 
sommige spieren was er bovendien een patroon te zien dat niet correspondeerde 
met het patroon van gezonde personen die normaal liepen. We concludeerden dat 
Lokomat lopen een lagere spieractiviteit kan veroorzaken die mogelijk verklaard 
kan worden door de lichaamsgewichtondersteuning, de hulp van de orthosen of de 
verminderde vrijheidsgraden van de Lokomat.
In hoofdstuk 3 hebben we de invloed bestudeerd van de hulp van de Lokomat en 
de verminderde vrijheidsgraden tijdens lopen in de Lokomat op het cardiorespiratoire 
systeem door het meten van de hartslag (HR) en de zuurstofopname (V̇O2) 
tijdens lopen in de Lokomat en tijdens normaal lopen. We concludeerden dat de 
inspanningsintensiteit tijdens lopen in de Lokomat ‘licht’ was volgens algemene 
aanbevelingen voor inspanningsintensiteit en lager dan normaal lopen. Deze 
resultaten suggereren dat dit de therapie waarschijnlijk geen grote verandering in de 
cardiorespiratoire fitheid zal veroorzaken. Bovendien hebben we gedemonstreerd 
dat andere combinaties van instellingen van de Lokomat niet leidden tot hogere 
cardiorespiratoire intensiteit in gezonde proefpersonen. Deze resultaten suggereren 
dat het onwaarschijnlijk is dat er een substantiële inspanningsintensiteit gerealiseerd 
kan worden bij patiënten met de combinaties van instellingen die we hebben 
onderzocht in dit experiment. 
In hoofdstuk 4 hebben we de effectiviteit van Lokomat therapie onderzocht 
in het verbeteren van de loopvaardigheid in niet-zelfstandig lopende patiënten 
tijdens de revalidatie na een beroerte. De patiënten in de interventiegroep kregen 
gedurende 8 weken 2 uur per week Lokomat training in combinatie met 3 keer 30 
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minuten conventionele therapie gericht op loopvaardigheid. De controlegroep kreeg 
gedurende evenveel uur alleen conventionele therapie gericht op het verbeteren 
van de loopvaardigheid. Bij start van de studie, direct na de interventieperiode en 
op 24 en 36 weken na de start van de studie werd de loopvaardigheid vastgelegd. 
Tijdens de revalidatie gingen patiënten significant vooruit in de loopsnelheid, op 
functie en mobiliteit en op kracht van het paretische been. Er werden echter geen 
significante verschillen gevonden in de verbetering van uitkomstwaarden tussen 
de interventiegroep en de controlegroep. Bovendien was de ‘effect size’ van de 
verschillen in vooruitgang direct na de interventieperiode voor alle uitkomstwaarden 
klein. Daarom concludeerden we dat Lokomat therapie net zo effectief is als 
conventionele therapie in het verbeteren van de loopvaardigheid bij patiënten na 
een beroerte. 
In hoofdstuk 5 hebben we de relaties tussen balans en kracht van de paretische 
kniestrekkers bestudeerd op verschillende momenten tijdens het revalidatieproces. 
Balans en kracht kunnen na een beroerte beiden duidelijk aangedaan zijn. In 
verschillende cross-sectionele studies is er aangetoond dat deze variabelen 
gerelateerd zijn aan elkaar. Echter, tijdens de revalidatie veranderen beiden, en we 
weten niet wat dit voor invloed heeft op de relatie op verschillende momenten. 
Uit de resultaten bleek een significante relatie tussen de absolute waarden op 
verschillende meetmomenten die sterker leek te worden over de tijd. Deze bevinding 
kan worden verklaard door de combinatie van een relatie tussen initiële aandoening 
en de verbetering in functie en, ten tweede, dat functionele vaardigheden 
kunnen verbeteren door compensatie strategieën. Bovendien vonden we een 
significante relatie tussen veranderingen in kracht van de paretische kniestrekkers 
en veranderingen in balans over het interval van wk1-wk10 van de studie (relatief 
vroeg na revalidatie), terwijl er geen significante relatie was tussen veranderscores 
voor het interval van wk10-wk24 van de studie (relatief laat na revalidatie). Deze 
resultaten kunnen mogelijk worden verklaard doordat verbeteringen in functionele 
vaardigheden mogelijk meer gerelateerd zijn aan verbeteringen in vrijwillige activatie 
dan aan verbeteringen in de grootte van de spier. Een andere verklaring is mogelijk 
dat er inter-individuele verschillen zijn in verbetering van balans of verbeteringen van 
bijvoorbeeld sensorische functie die de balans beïnvloeden. 
Interventies gericht op het bevorderen van fysieke activiteit bij mensen 
met een dwarslaesie worden steeds belangrijker omdat fysieke activiteit de 
gezondheid kan bevorderen. Daarom hebben we in hoofdstuk 6 de effecten van 
een periode van Lokomat training op de cardiorespiratoire fitheid bestudeerd. Het 
trainingsprogramma bestond uit 24 trainingen met de Lokomat in combinatie met 
conventionele therapie. Om de cardiorespiratoire intensiteit vast te leggen werd 
zuurstofopname en hartfrequentie gemeten tijdens training met de Lokomat. 
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envatting
151
Cardiorespiratoire fitheid werd gemeten voor de interventieperiode en na de 
interventieperiode tijdens een inspanningstest met een arm ergometer. Resultaten 
lieten zien dat de inspanningsintensiteit tijdens lopen in de Lokomat’ licht’ was 
volgens algemene aanbevelingen voor inspanningsintensiteit. De resultaten van 
de inspanningtest lieten echter een significant lagere submaximale- en rusthartslag 
zien na interventie terwijl er geen significante verschillen waren in zuurstofopname, 
wijzend op een hoger slagvolume. Echter de zuurstofpulse verbeterde niet significant. 
We concludeerden daarom dat ondanks de lichte intensiteit van Lokomat therapie, 
deze interventie een positief effect zou kunnen hebben op cardiorespiratoire fitheid. 
Echter de verbetering in cardiorespiratoire fitheid is waarschijnlijk klein.
In hoofdstuk 7 hebben we de effecten bestudeerd van een interventie van 24 
Lokomat trainingen met extra conventionele therapie gericht op het verbeteren van 
loopvaardigheid, verdeeld over maximaal 4 maanden. Alhoewel er op groepsniveau 
significante verbeteringen gevonden werden was er behoorlijk wat variatie in de 
grootte van de verbetering binnen de groep patiënten. Bovendien suggereert 
dat het uitblijven van een effect op alle uitkomstwaarden die gerelateerd zijn aan 
loopvaardigheid dat de verbeteringen klein waren. We concludeerden dat patiënten 
sommige aspecten van loopvaardigheid verbeteren tijdens de interventie met 
Lokomat therapy en extra conventionele therapie, maar de verbeteringen zijn in de 
meeste patienten klein.
Tot slot zijn de implicaties van recente inzichten bediscussieerd en worden er 
aanbevelingen voor toekomstig onderzoek gedaan in hoofdstuk 8. De literatuur 
over dierstudies en motorisch leren suggereren dat herstel van functionele 
vaardigheden na neurologisch letsel mogelijk is door oefening. Er is echter nog 
steeds een kloof tussen het veronderstelde mogelijke  herstel na een beroerte en 
na dwarslaesie en wat we tot nu toe hebben bereikt met interventies. Onderzoek 
moet zich richten op het optimaliseren van therapie op basis van wat we nu weten. 
Bovendien is het essentieel om kennis te vergaren over hoe de Lokomat optimaal 
gebruik moet worden in termen van instellingen zoals de snelheid, hoeveelheid 
lichaamsgewichtsondersteuning, hoeveelheid en type hulp van de orthosen en de 
duur en frequentie van de trainingen, voordat er een definitief oordeel gegeven kan 
worden over de effectiviteit van de Lokomat of vergelijkbare apparaten. Onderzoek 
moet zich ook richten op het identificeren van eventuele subgroepen van patiënten 
die mogelijk profijt hebben van deze therapie. Om hierin te slagen is het essentieel 
dat verschillende revalidatie instituten gaan samenwerken om deze informatie te 
verzamelen. Verder in de toekomst zullen nieuwe behandelingen ontwikkeld worden 
die onze kennis over motorisch leren combineren met nieuwe therapieën (zoals 
brein of ruggenmerg stimulatie). In deze toekomstige ontwikkelingen is er mogelijk 
nog een belangrijke rol weggelegd voor robotische systemen.
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Aan het tot stand komen van dit proefschrift hebben veel mensen meegewerkt 
die ik daarvoor hartelijk wil bedanken. In de eerste plaats gaat mijn dank natuurlijk 
uit naar alle patiënten die hebben meegedaan aan de studies beschreven in dit 
proefschrift, of met wie ik heb gewerkt aan andere studies. Meer dan eens heb ik 
jullie verdraagzaamheid getest als het gaat om de liesbanden van de Lokomat, het 
comfort van ‘mijn’ stoel, de prikkelende stimulatie van jullie benen of weer het 
zoveelste testje. Ik heb ons contact altijd gewaardeerd en wens jullie al het beste 
voor de toekomst! 
Uiteraard wil ik mijn promotieteam Arnold de Haan, Thomas Janssen en Karin 
Gerrits hartelijk danken voor de energie die in mijn project is gestoken. Beste Karin, 
ik weet niet hoe je het doet, maar met minder dan een full-time aanstelling op de 
faculteit zo veel werk verzetten is ongelofelijk knap. Ik had nogal eens je hulp nodig 
om resultaten, conclusies en speculaties uit elkaar te houden. Ik wil je bedanken voor 
de scherpe vragen die je me gesteld heb waarmee je me tot nadenken hebt aangezet, 
terwijl ik dacht dat het zonneklaar was. Beste Thomas, met het opzetten van het 
laboratorium bij Reade heb je de revalidatiewetenschappen een grote dienst bewezen. 
Ik ben benieuwd waar je nieuwste initiatief voor een test en trainingscentrum voor 
aangepast sporten toe zal leiden. Ik bewonder de manier waarop je reclame maakt 
voor (ons) onderzoek binnen de revalidatiewereld. Ik wil je danken voor de positieve 
kijk op de resultaten van mijn onderzoeken als ik zelf even niet meer zo goed wist 
welke kant ik ermee op moest. Beste Arnold, alhoewel je misschien iets verder van de 
revalidatiepraktijk afstond slaagde je er vaak in om duidelijk richting te geven aan wat 
er uiteindelijk voor boodschap op papier moest komen te staan. Met name tijdens 
de eindfase was het fijn om bij je binnen te kunnen vallen om even kort met je van 
gedachten te wisselen over waar ik op dat moment mee zat.
Het onderzoek heeft plaats gevonden in het Duyvensz-Nagel 
onderzoekslaboratorium bij Reade op de Overtoom. Natuurlijk heb ik hier met heel 
veel mensen samengewerkt en wil ik iedereen bedanken voor een hele fijne tijd! Een 
aantal mensen wil ik specifiek bedanken. Allereerst natuurlijk Myrthe Pticek en Sylvia 
Imminkhuizen. Myrthe, jij hebt me in het begin van mijn promotie geholpen met het 
zorgen dat alle metingen en therapieën netjes volgens de opzet van de onderzoeken 
verliepen. Silvia, jij hebt Myrthe opgevolgd als het gaat om het plannen van de 
werkzaamheden voor het onderzoek bij mensen met beroerte. Dan Ivonne Wolters 
en Yvonne Quanjel, jullie wil ik ook graag bedanken voor jullie planwerkzaamheden 
voor het onderzoek bij mensen met dwarslaesie. Ik geloof dat ik jullie af en toe tot 
het uiterste heb gedreven als er weer eens iets tussendoor geregeld moest worden. 
Zonder jullie was het echt niet gelukt om mijn promotie tot een goed einde te 
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brengen, super bedankt daarvoor! Een aantal therapeuten wil ik ook graag bij naam 
noemen: Frank Ettema en Hetty Kooijmans. Jullie zijn met jullie enthousiasme voor 
het toepassen van de Lokomat in jullie behandelpraktijk erg belangrijk geweest 
voor het slagen van het onderzoek naar de effectiviteit van de Lokomat. Ik vond 
het erg prettig om met jullie samen te mogen werken en heb veel van jullie geleerd 
over hoe revalidatie in de praktijk gaat. Dan zijn er nog mijn collega’s van het DNO, 
Mariëlle, Sonja, Ellen en Dieuwke; bedankt voor de gastvrijheid, gezelligheid en 
medewerking! Als laatste wil ik Janneke Stolwijk, Christof Smit, Manin Konijnenbelt, 
Kirsten Nienhuys, wijlen Peter Koppe en alle AIO’s bedanken voor hun inzet voor het 
onderzoek.
Vooral in de laatste periode van mijn promotie ben ik werkzaam geweest op 
de VU. Natuurlijk zijn er ook hier weer veel mensen die ik zou wil noemen in mijn 
dankwoord. Ik wil allereerst mijn verontschuldigingen maken aan mijn oude roomies 
Daphne, Regula en Marcel; sorry dat ik er bijna nooit was…Dan bedank ik natuurlijk 
zeker mijn huidige roomies, Kim, Marieke en Mariëlle voor hun gezelligheid, mooie 
trouwfoto’s, en blik snoep (heb ik heel erg gewaardeerd). Zonder andere mensen 
tekort te doen wil ik als laatste ook graag Gert Kwakkel, Melvyn Roerdink, Joost van 
Kordelaar, Rinske Nijland, Arjan Bakkum, Jan van der Scheer en Femke Hoekstra 
danken voor het van gedachten wisselen over inhoud en invulling van ons vakgebied 
en mijn proefschrift. Bovendien wil ik ook graag de technische ondersteuning en 
specifiek Peter Verdijk bedanken voor de hulp bij het realiseren van opstellingen en 
software nodig voor de experimenten.
En dan zijn er nog de familie en vrienden. Pa, mam, bedankt voor jullie 
onvoorwaardelijke steun voor alles waar ik me mee bezig houd. Mijn grote broers 
Joris en Bram; wat is het toch lekker om de jongste ‘labzwans’ te zijn. Kan niet 
wachten tot we weer gezamenlijk bier gaan drinken met ons vaders! Ivo en Mark, 
supergaaf dat jullie mijn paranimfen zijn voor de ceremonie, eigenlijk hoort Maarten 
er ook bij te staan, for good old sake.
De laatste dikke zoen gaat uit naar Inge, Inkie, mijn liefje. Gewoon omdat je het 
aller leukste vriendinnetje bent! Ontzettend bedankt voor je liefde, knuffels en plek 
voor mij in je leven en op de bank. Ik hoop samen nog veel met je te mogen beleven, 
en dat gaat nu vast goed komen nu mijn promotie erop zit.
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